Home
Clint Login
Become A Client: Register Now
(Clinic (or) Hospital (or) Doctor (or) Collection Center)
S.No | Test_Code | Test Type | Method | Description | Sample | Schedule | TAT |
---|---|---|---|---|---|---|---|
S.No | Test_Code | Test Type | Method | Description | Sample | Schedule | TAT |
1 | BGSNG72 | SANGERS SEQUENCING | MLPA + Sanger's | MGMT METHYLATION BY MLPA + SANGERS | FFPE TISSUE BLOCK | DAILY | 10 |
2 | BGPCR851A | Molecular | Real Time PCR | HPV INDIVIDUAL HIGH RISK GENOTYPES DETECTION HPV - 16, 18,31, 33, 35, 39,45,51,52,56,58,59 & 68 | LBC | DAILY | 2 DAYS |
3 | BGGN451 | Routine Markers/Panels | ELISA | LEAD - URINE | URINE | DAILY | 3 DAYS |
4 | BGGN450 | Routine Markers/Panels | ELISA | NEURON SPECIFIC ENOLAASE (NSE) | Serum (2 mL) | DAILY | 8 DAYS |
5 | GPNGS032 | WHOLE EXOME SEQUENCING | NGS | GENE POWER WES - Hemoglobinopathies and Anaemia | WB EDTA | DAILY | 21 DAYS |
6 | BGGN449 | Routine Markers/Panels | ELISA | ANTI B TITRE | WB- EDTA | 2 DAYS | 3 DAYS |
7 | BGGN448 | Routine Markers/Panels | BIOCHEMISTRY | PORPHYRINS TOTAL | URINE | 2 DAYS | 4 DAYS |
8 | GPNGS031 | WHOLE EXOME SEQUENCING | NGS | MYGUT MICROBIOME 16S rRNA based Metagenomics of gut microorganisms | STOOL / FAECUS | DAILY | 21 Days |
9 | BGPCR944 | Molecular | Real Time PCR | Chlamydia pneumoniae DNA PCR (Qualitative) | Nasal Swab, Throat Swab, Sputum, BAL | DAILY | 2 DAYS |
10 | BGPCR943 | Molecular | Real Time PCR | FEVER PROFILE PCR PANEL - 6 TARGETS Chikungunya, Dengue, Malaria, Typhoid, Leptospira and Zika Virus | WB EDTA, SERUM | DAILY | 3 Days |
11 | BGGN447 | Routine Markers/Panels | ELISA | ANTI -A TITRE | Serum (2 mL) | DAILY | 3 DAYS |
12 | GPONCO087A | ONCOLOGY BASED NGS | NGS | 28 Homologous Recombination Genes : ATM, BARD1, BRCA2, BRCA1, BRIP1, CDK12, CHEK2, CHEK1, FANCD2, FANCL, KRAS, MRE11, NB | FFPE / WB EDTA | DAILY | 21 |
13 | BGPCR850A | Molecular | Sanger's Sequencing | HIV -1 Drug Resistance Mutations Assay (PI, NRTI, NNRTI, INSTI) | WB EDTA | DAILY | 21 Days |
14 | BGPCR901A | Molecular | Real Time PCR | PNEUMONIA PCR PANEL | BAL, SWAB, BRONCHIAL WASH, SPUTUM | DAILY | 2 DAYS |
15 | BGGNP087 | Routine Markers/Panels | BIOCHEMISTRY, IMMUNOLOGY | WOEM CANCER PREVENTION PACKAGE CBC, LFT, KFT, TFT, LIPID Pfofile, CA72.4, CAA 15.3, CA 19.9, CEA, CA125 | WB EDTA, SERUM | DAILY | 2 DAYS |
16 | BGGNP086 | Routine Markers/Panels | BIOCHEMISTRY, IMMUNOLOGY | MEN CANCER PREVENTION PACKAGE CBC, LFT, KFT, TFT, LIPID Pfofile, CA72.4, CA 19.9, CEA, PSA (Total & Free) | WB EDTA, SERUM | DAILY | 2 DAYS |
17 | BGGNP082A | Routine Markers/Panels | EIA/BIOCHEMISTRY | NEW BORN SCREENING BASIC PANEL - 17-OHP, BIOTINIDASE, GALACTOSEMIA TSH, CYSTIC FIBROSIS, G6PD, PHENYL ALANINE - 7 Markrs | Hell Prick Blood on Card | DAILY | 5 DAYS |
18 | BGPCR942 | Molecular | PCR Fragment Analysis | HUNTINGTON DISESE Genetic Testing | WB EDTA | DAILY | 5 DAYS |
19 | BGGNP085 | Routine Markers/Panels | EIA, CLIA | Type 1 Diabetic Autoimmune Profile - Islet Cell Autoantibodies GAD65 Antib | SERUM | DAILY | 5 Days |
20 | BGPCR917A | Molecular | Real Time PCR | Hepatitis A Virus RNA PCR Quantitative | WB EDTA, SERUM | Daily | 3 DAYS |
21 | BGFL904 | Flowcytometry | FLOWCYTOMETRY | ALL/AML/CLL Customized Panel - upto 8 markers | WB / BM in Hep & EDTA | Daily | 3 Days |
22 | BGPCR941 | Molecular | LUMINEX / NGS | HLA Typing - for CELIAC Disease | WB - EDTA | DAILY | 5 DAYS |
23 | BGGN446 | Routine Markers/Panels | ELISA | Anti Diuretic Hormone - ADH | PLASMA-EDTA | 3 DAYS | 5 DAYS |
24 | BGGNP084 | Routine Markers/Panels | BIOCHEMISTRY, IMMUNOLOGY | GENEPOWER X HEALTH PROFILE - CBP, HBA1C, RFT, LFT, LIPID PROFILE, TFT | SERUM, WB-EDTA | DAILY | 24 HRS |
25 | BGGN445 | Routine Markers/Panels | CLIA | VITAMIN - B1 | WB-EDTA | 2 DAYS | 4 DAYS |
26 | BGGNP083 | Routine Markers/Panels | EIA / CLIA | PROSTRATE HEALTH INDEX - PSA Total, PSA Free & Pro PSA (P2PSA) | SERUM 2mL | DAILY | 2 DAYS |
27 | BGGNP082 | Routine Markers/Panels | DELFIA | NEW BORN SCREENING EXTENDED PANEL - 17-OHP, BIOTINIDASE, GALACTOSEMIA TSH, CYSTIC FIBROSIS, G6PD, Amino Acids, Organic A | Heel prick blood on filter paper | Daily | 3 DAYS |
28 | BGGN444 | Routine Markers/Panels | EIA | PRE PRO PSA (Prostate Specific Antigen) (P2 PSA) | SERUM 2mL | DAILY | 24 HOURS |
29 | BGGN443 | Routine Markers/Panels | DELFIA | PHENYL ALANINE (New Born Screen) | HEEL PRICK BLOOD ON FILTER PAPER | DAILY | 2 DAYS |
30 | BGGN442 | Routine Markers/Panels | DELFIA | GELACTOSEMIA, New Born Screen | HEEL PRICK BLOOD ON FILTER PAPER | DAILY | 2 DAYS |
31 | BGGN441 | Routine Markers/Panels | EIA | ANTI GANGLIOSIDE ANTIBODY IgG or IgM EACH | SERUM 2mL | DAILY | 4 DAYS |
32 | BGPCR940 | Molecular | real time PCR | MALARIA - PLASMODIUM SPS PCR (Pf & Pv) | WB EDTA, Seruum | DAILY | 24 Hours |
33 | BGGNP081 | Routine Markers/Panels | IMMUNOBLOT | MYOSITIS IMMUNOBLOT ASSAY - 18 MARKERS | SERUM | DAILY | 4 DAYS |
34 | BGPCR939 | Molecular | real time PCR | HUMAN METAPNEUMO VIRUS RNA QUALITATIVE | SWAB - NASO/ORO | DAILY | 1 DAY |
35 | BGGN440 | Routine Markers/Panels | ELISA | SEROTONIN SERUM | Serum | DAILY | 4 DAYS |
36 | BGGN439 | Routine Markers/Panels | ELISA | DOPAMINE in BLOOD | WB EDTA | DAILY | 4 DAYS |
37 | BGPCR862A | Molecular | real time PCR | PARVO VIRUS B19 DNA Quantitative PCR | WB, Urine, Body Fluids | DAILY | 2 DAYS |
38 | BGPCR807A | Molecular | real time PCR | BCR/ABL CML: Major (p210) ALL: Minor (p190) Micro (p230) | WB / BM in EDTA | DAILY | 2 DAYS |
39 | BGPCR938 | Molecular | real time PCR | MRSA - Methicillin Resistance Stapylococcus Aureus Assay Detection of Staphylococcus aureus and Drug resisance | Sputum, Nasal Swab | DAILY | 3 DAYS |
40 | BGSNG71 | SANGERS SEQUENCING | SANGERS | PATERNITY TESTING - 2 PARENTS & 1 CHILD STR ANALYSIS by IDENTIFILER | WB in EDTA | DAILY | 7 DAYS |
41 | BGSNG70 | SANGERS SEQUENCING | SANGERS | PATERNITY TESTNG - 1 PARENT & CHILD | WB in EDTA | DAILY | 7 DAYS |
42 | BGPCR936 | Molecular | real time PCR | Pneumocystis PCR Qualitative (Pneumocystis jirovecii) | Sputum, BAL, VTM, Tracheal Aspirate | DAILY | 4 DAYS |
43 | BGPCR884C | Molecular | real time PCR | VIRAL MENINGITIS PANEL | CSF | DAILY | 2 DAYS |
44 | BGPCR884A | Molecular | real time PCR | VIRAL, BACTERIAL & FUNGAL MENINGITIS PANEL | CSF | DAILY | 2 DAYS |
45 | BGGNP080 | Routine Markers/Panels | ELISA, CLIA | HBV HCV & HIV SCREENIN PANEL HBsAg, Anti HCV and HIV 1 & 2 - Ag/Ab for Dialysis and Transplant patients | WB-EDTA, Serum | DAILY | 1 DAY |
46 | GPONCO089 | ONCOLOGY BASED NGS | NGS | BRCA1 & BRCA2 with Deletions and Duplications (Germline) | WB in EDTA | DAILY | 21 days |
47 | GPONCO088 | ONCOLOGY BASED NGS | NGS | ONCORx - MICROSATELLITE INSTABILITY (MSI) 13 MSI Biomarkers | FFPE TISSUE | DAILY | 21 days |
48 | GPONCO087 | Routine Markers/Panels | NGS | ONCORx – Homologous Recombination Repair Genes 14 Genes | FFPE TISSUE | DAILY | 21 days |
49 | GPONCO086 | ONCOLOGY BASED NGS | NGS | TRK Inhibitors Response Prediction (NTRK1, 2, 3 Fusion analysis for all solid tumors) GGS / fusion analysis | FFPE TISSUE | DAILY | 21 days |
50 | GPONCO085 | ONCOLOGY BASED NGS | NGS | ONCORx – FUSION: TARGETED ONCO PANEL FOR SOMATIC RNA Analsis 72 SNPs, InDels targets 102 Fusion targets (Known and no | FFPE TISSUE | DAILY | 21 days |
51 | GPONCO083 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: GASTRO INTESTINAL STROMAL TUMOR GIST 21 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
52 | GPONCO081 | ONCOLOGY BASED NGS | NGS | ONCORx CSP - DERMATO FIBRO SARCOMA - Protuberans 19 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
53 | GPONCO080 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : HISTIOCYTOSIS 8 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
54 | GPONCO079 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : WILMS TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
55 | GPONCO078 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP :VULVAR CARCINOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
56 | GPONCO077 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : VAGINAL CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
57 | GPONCO076 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : UNDIFFERENTIATED EMBRYONAL SARCOMA OF THE LIVER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
58 | GPONCO075 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : TUBULAR ADENOMA OF THE COLON 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
59 | GPONCO082 | ONCOLOGY BASED NGS | NGS | ONCO Rx CSP - COLORECTAL ADVANCED CANCER PANEL 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
60 | GPONCO084 | ONCOLOGY BASED NGS | NGS | ONCO RX - TMB (TUMOR MUTATION BURDEN) | FFPE TISSUE | DAILY | 21 DAYS |
61 | BGPCR935 | Molecular | Real Time PCR | URINARY TRACT INFECTION - Comprehensive Panel | URINE | DAILY | 2 DAYS |
62 | BGPCR914 | Molecular | SANGERS + CYTO | QF PCR PANEL (13,18,21,X & Y) + KARYOTYPING + MATERNAL CELL CANTIMANATION | AMIO ,CORD BLOOD | DAILY | 07 DAYS |
63 | BGPCR809A | Molecular | real time PCR | BCR/ABL (ALL)MINOR(p190) Quantitative | WB/BM in EDTA | DAILY | 2 Days |
64 | BGSNG68 | SANGERS SEQUENCING | Sangers | Hepatitis C Virus (HCV) – Genotyping | WB in EDTA | DAILY | 3 DAYS |
65 | BGSNG67 | SANGERS SEQUENCING | Sangers | Hepatitis B Virus (HBV) Drug Resistance Assay | WB in EDTA | DAILY | 3 DAYS |
66 | BGSNG66 | SANGERS SEQUENCING | Sangers | Hepatitis B Virus (HBV) – Genotyping | WB in EDTA | DAILY | 3 DAYS |
67 | BGSNG65 | SANGERS SEQUENCING | Sangers | AML - NPM1 ( Nucleophosmin -1) gene mutation Assay | WB in EDTA | DAILY | 7 DAYS |
68 | BGSNG64 | SANGERS SEQUENCING | Sangers | AML - FLT3 (fms like tyrosine kinase 3) Gene Mutation Assay | WB in EDTA | DAILY | 7 DAYS |
69 | BGSNG63 | SANGERS SEQUENCING | Sangers | AML - CEBPA (CCAAT/Enhancer Binding Protein) mutations | WB in EDTA | DAILY | 7 DAYS |
70 | BGSNG62 | SANGERS SEQUENCING | Sangers | AML PCR PANEL II - FLT3, NPM1 & C/EBPA ( With Normal Cytogenetics) | WB in EDTA | DAILY | 7 DAYS |
71 | BGSNG61 | SANGERS SEQUENCING | Sangers | KRAS, NRAS, BRAF MUTATION ANALYSIS | WB in EDTA | DAILY | 7 DAYS |
72 | BGPCR934 | Molecular | real time PCR | SEPSIS PANEL - Gram Positive, Gram Negative, Fungal pathogens | WB, Serum, CSF, Body Fluids | DAILY | 2 DAYS |
73 | BGPCR933 | Molecular | real time PCR | GLYCOPEPTIDE PANEL (vanA and vanB) | WB, Urine, Swab, Body Fluids | DAILY | 2 DAYS |
74 | BGPCR932 | Molecular | real time PCR | GRAM POSITIVE BACTERIAL PANEL (S. pneumoniae, S. aureus, E. faecalis, C. difficile, L. monocytogenes) | WB, Urine, Swab, Body Fluids | DAILY | 2 DAYS |
75 | BGPCR931 | Molecular | real time PCR | GRAM NEGATIVE BACTERILA PANEL - 2 (H. influenzae, S. typhi, and Enterobacter sp.) | WB, Urine, Swab, Body Fluids | DAILY | 2 DAYS |
76 | BGPCR930 | Molecular | real time PCR | GRAM NEGATIVE BACTERIAL PANEL - 1 (P. aeruginosa , E.coli, Klebsiella sp., and A. baumannii) | WB, Urine, Swab, Body Fluids | DAILY | 2 DAYS |
77 | BGPCR929 | Molecular | real time PCR | GASTROENTERITIS / GASTROINTESTINAL PANEL | Stool / Rectal swab / gastro duodenal aspirate | DAILY | 2 DAYS |
78 | BGPCR928 | Molecular | real time PCR | FEVER (Tropical) PROFILE COMPREHENSIVE - Salmonella, Plasmodium, Chikungunya, Dengue, Leptospira, Zika, West Nile Virus | WB in EDTA, Serum | DAILY | 2 DAYS |
79 | BGPCR927 | Molecular | real time PCR | FEVER (Tropical) PROFILE MINI - Salmonella, Plasmodium, Chikungunya, Dengue | WB in EDTA, Serum | DAILY | 2 DAYS |
80 | BGPCR926 | Molecular | real time PCR | Colistin + Fluoroquinolones Panel A (mcr-1, mcr-3 and mcr-8) | WB, Urine, Swab | DAILY | 2 DAYS |
81 | BGPCR925 | Molecular | real time PCR | Carbapenemases Panel B (kpc, vim and imp) | WB, Urine, Swab | DAILY | 2 DAYS |
82 | BGPCR924 | Molecular | real time PCR | Carbapenemases Panel A (ndm, oxa-23 and oxa-48) | WB, Urine, Swab | DAILY | 2 DAYS |
83 | BGPCR923 | Molecular | real time PCR | Beta-lactamases Resistance Extended-spectrum (ESBL) (CTX-M-1, and CTX-M-9) | WB, Urine, Swab | DAILY | 2 DAYS |
84 | BGPCR922 | Molecular | real time PCR | Beta-lactamases Resistance Panel Basic (mecA, and mecC) | WB, Urine, Body Fluids | DAILY | 2 DAYS |
85 | BGPCR921 | Molecular | real time PCR | AMINOGLYCOSIDE B PANEL (aac(3)-Ia, -Ib, -Id, aac(3)-Iid, aac(6')-Ib, aac(6')-Ii, aac(6‘)-Ie-aph(2'')-Ia, aph(3')-Ia, | WB, Urine, Swab | DAILY | 2 DAYS |
86 | BGPCR920 | Molecular | real time PCR | AMINOGLYCOSIDE A PANEL (armA, rmtB & rmtC) | WB, Urine, Swab | DAILY | 2 DAYS |
87 | BGGN437 | Routine Markers/Panels | EIA | CSF (CEREBRO SPINAL FLUID) - IgG INDEX | CSF 2mL | DAILY | 2 DAYS |
88 | BGHP342 | HPE & IHC | AUTOMATED IHC | PDL 1 on AUTOMATED IHC VENTANA / DAKO AUTOSTAINER | FFPE | DAILY | 9 DAYS |
89 | BGHP486 | HPE & IHC | IHC | IHC MARKERS - SEVEN MARKERS.. | FFPE TISSUE BLOCK.. | 5 DAYS | 5 DAYS |
90 | BGPCR919 | Molecular | real time PCR | BCR ABL Major (p210) Minor (p190) & Micro (p230) detection & quantification | WB/BM in EDTA | DAILY | 48 Hrs |
91 | BGPCR918 | Molecular | REAL TIME PCR | PAN FUNGAL QUALITATIVE PANEL INCULDED Candid | BODY FLUIDS, SERUM | DAILY | 2 DAYS |
92 | BGPCR917 | Molecular | Real Time PCR | Hepatitis E Virus RNA PCR Quantitative | WB EDTA, SERUM | DAILY | 2 DAYS |
93 | BGGN436 | Routine Markers/Panels | BIOCHEMISTRY | HEAVY METAL SCREENING | WB-EDTA | DAILY | 07 DAYS |
94 | BGGN283 | Routine Markers/Panels | ELISA | NOR METANEPHRINES, FREE | PLASMA EDTA | DAILY | 2 DAYS |
95 | BGGN264 | Routine Markers/Panels | ELISA | Metanephrines - Free | PLASMA EDTA | DAILY | 2 DAYS |
96 | BGPCR 830 - 34 | Molecular | Real Time PCR | HBV DNA QUAL & HCV RNA QUAL - PCR | WB EDTA | DAILY | 2 DAYS |
97 | BGGN434 | Routine Markers/Panels | Microscopy | FUNGAL STAIN | CSF,TISSUE BODY FLUIDS,SPUTUM | DAILY | 24 HRS |
98 | GPNGS030 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - CSP WES WHOLE EXOME SEQUENCING 385 GENES / SNPs, InDels | WB EDTA | DAILY | 21 DAYS |
99 | BGGN435 | Routine Markers/Panels | BIOCHEMISTRY | MICROALBUMIN : CREATININE RATIO (ACR) | URINE 5ml | DAILY | 24 HRS |
100 | BGPCR916 | Molecular | Real Time PCR | Ricketsia DNA Qalitative | WB EDTA, SERUM, BODY FLIDS | DAILY | 2 DAYS |
101 | BGPCR915 | Molecular | Real Time PCR | SALMONELLA TYPHI DNA QUALITATIVE | WB EDTA, SERUM BODY FLUID | DAILY | 2 DAYS |
102 | BGFH739 | Cytogenetics | CYTOGENETICS - FISH | NTRK GENES 1, 2, 3 FISH | FFPE Tissue Block | DAILY | 7 DAYS |
103 | BGGN433 | Routine Markers/Panels | EIA | EPSTEIN BARR VIRUS IgM FOR NUCLEAR ANTIGEN | Serum (2 mL) | DAILY | 2 DAYS |
104 | BGGN432 | Routine Markers/Panels | EIA | EPSTEIN BARR VIRUS IgG FOR NUCLEAR ANTIGEN | Serum (2 mL) | DAILY | 2 DAYS |
105 | BGGN431 | Routine Markers/Panels | EIA | PIVKA II (DES-GAMMA CARBOXY PROTHROMBIN - DCP) | Serum (2 mL) | DAILY | 4 Days |
106 | BGGN430 | Routine Markers/Panels | BIOCHEMISTRY | BLOOD UREA NITROGEN (BUN) | Serum (2 mL) | DAILY | 1 DAY |
107 | BGFH738 | Cytogenetics | FISH & KARYOTYPING | ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS - FISH (4 MARKERS) + KARYOTYPING | WB / BM in Na HEPARIN & EDTA | DAILY | 6 days |
108 | BGGNP079 | Routine Markers/Panels | CLIA, EIA | VITAMIN PROFILE FOLIC ACID, VITAMIN B12, 25-OH- VITAMIN D (Total) | SERUM | DAILY | 1 Day |
109 | BGGNP077 | Routine Markers/Panels | HAEMATOL, BIOCHEM, IMMUNO | HAIR FALL HEALTH CHECK UP - CBP, CALCIUM, FERRITIN, IRON, TSH, VIT. B12, VIT. D TOTAL | WB EDTA, SERUM | DAILY | 2 DAYS |
110 | BGGNP078 | Routine Markers/Panels | CLIA, EIA | THYROID ANTIBODY PANEL - ANTI THYROGLOBULIN ANTIBODY (ATG), ANTI TPO, TSH RECEPTOR ANTIBODIES | Serum (2 mL) | DAILY | 2 DAYS |
111 | BGGNP076 | Routine Markers/Panels | BIOCHEMISTRY, EIA | DIABETIC ADVANCED PROFILE FBS, PLBS, HBA1C, RFT, LIPID PROFILE, LFT, SERUM INSULIN, C PEPTIDE, URINE MICROALBUMIN | WB EDTA, FLOURIDE, SERUM, URINE | DAILY | 1 DAY |
112 | BGGNP075 | Routine Markers/Panels | BIOCHEMISTRY | DIABETIC EXTENDED PROFILE FBS, PLBS, HBA1C), Serum Creatinine, Cholesterol Total, SGOT, SGPT , Urine Mictoalbumin | WB-EDTA, FLOURIDE, URINE, SERUM | DAILY | 1 DAY |
113 | BGGNP074 | Routine Markers/Panels | Biochemistry, Immunology | CARDIAC RISK PROFILE - APO A1, APO B1, APO B1 / APO A1 Ratio, Homocystine, HS CRP, Lipoprotein A, Lipoprotein -Associat | WB EDTA, SERUM | DAILY | 2 DAYS |
114 | BGGNP073 | Routine Markers/Panels | BIOCHEMISTRY, CLIA, HEMATOLOGY | MASTER HEALTH CHECK UP CALCIUM, CUE, CBP, ESR, FBS, HBA1C, KFT, LFT, UREA, URIC ACID, TFT , VIT B12, VIT D | WB EDTA, SERUM, URINE | DAILY | 24 HRS |
115 | BGGNP072 | Routine Markers/Panels | BIOCHEMISTRY, CLIA | GASTRIC HEALTH PANEL LFT, CBP, AMYLASE & LIPASE, Serum GASTRIN | WB EDTA,SERUM | DAILY | 1 DAY |
116 | BGGNP071 | Routine Markers/Panels | CLIA, EIA,COAGULATION | PHOSPHO LIPID SYNDROME PANEL: Cardiolipin IgG & IgM, APLP IgG & IgM, Lupus Anticoagulant, Beta 2 Glycoprotein IgG, Ig | Serum (2 mL), PLASMA Citrate | DAILY | 1 DAY |
117 | BGGNP070 | Routine Markers/Panels | HEM, BIOCHEM, IMMUNOL | SENIOR CITIZEN HEALTH PROFILE CBP, LFT, KFT, LIPD PROFILE, TFT, VIT D, VIT B12, CUE, IRON PROFILE | WB EDTA, SERUM, URINE | DAILY | 1 DAY |
118 | BGGNP069 | Routine Markers/Panels | CLIA | THYROID PROFILE EXTENDED - T3, T4, TSH, FT3, FT4 | Serum (2 mL) | DAILY | 1 DAY |
119 | BGGN429 | Routine Markers/Panels | LATERAL FLOW | Hepatitis B Surface Antigen (HBsAg) - Rapid Screening | PLASMA EDTA, SERUM | DAILY | 24 HRS |
120 | BGGN428 | Routine Markers/Panels | IMMUNOBLOT | HCV Antibody RAPID SCREENING (TRIDOT) | SERUM | DAILY | 24 HRS |
121 | BGGN427 | Routine Markers/Panels | IMMUNOBLOT | HIV 1 & 2 RAPID SCREENING, TRIDOT | PLASMA EDTA, SERUM | DAILY | 24 HRS |
122 | BGGNP064 | Routine Markers/Panels | ELISA | MYASTHENIA GRAVIS PANEL (ACETYLE CHOLINE RECEPTOR Ab & MUSK Ab) | SERUM | DAILY | 4 DAYS |
123 | BGPCR899A | Molecular | MICROARRAY | CHROMOSOMAL MICRO ARRAY (CMA) HIGH RESOLUTION - 750k | WB EDTA | DAILY | 14 DAYS |
124 | BGPCR913 | Molecular | Real Time PCR | MUMPS (MuV) VIRUS RNA QUALITATIVE | Buccal Swab / CSF / Urine | DAILY | 2 DAYS |
125 | BGGN425 | Routine Markers/Panels | LC-MS/MS | METHYL MALONIC ACID, QUANTITATIVE | SERUM | DAILY | 7 DAYS |
126 | BGGN424 | Routine Markers/Panels | CMIA | VITAMIN B12 ACTIVE - HOLOTRANSCOBALAMIN | SERUM | DAILY | 4 DAYS |
127 | BGGN423 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
128 | GPONCO074 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : THYMIC TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
129 | GPONCO073 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SOFT TISSUE CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
130 | GPONCO072 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SMALL CELL LUNG CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
131 | GPONCO071 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SMALL BOWEL CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
132 | GPONCO070 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SKIN CANCER, NON MELANOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
133 | GPONCO069 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SIALOBLASTOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
134 | GPONCO068 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SEX CORD STROMAL TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
135 | GPONCO067 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SELLAR TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
136 | GPONCO066 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : SALIVARY GLAND CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
137 | GPONCO065 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : RHABDOID CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
138 | GPONCO064 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP :RETINOBLASTOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
139 | GPONCO063 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP :RENAL NEUROENDOCRINE TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
140 | GPONCO062 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : RENAL CELL CARCINOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
141 | GPONCO061 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PRIMARY CENTRAL NERVOUS SYSTEM MELANOCYTIC TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
142 | GPONCO060 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PINEAL TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
143 | GPONCO059 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PHEOCHROMOCYTOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
144 | GPONCO058 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PERIPHERAL NERVOUS SYSTEM CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
145 | GPONCO057 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PENILE CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
146 | GPONCO056 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PARATHYROID CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
147 | GPONCO055 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : PANCREATIC CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
148 | GPONCO054 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : NERVE SHEATH TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
149 | GPONCO053 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MYOFIBROMATOSIS 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
150 | GPONCO052 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MISCELLANEOUS NEUROEPITHELIAL TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
151 | GPONCO051 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MISCELLANEOUS BRAIN TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
152 | GPONCO050 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MESOTHELIOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
153 | GPONCO049 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MELANOCYTOMA 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
154 | GPONCO048 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MALIGNANT RHABDOID TUMOR OF THE LIVER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
155 | GPONCO047 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : MALIGNANT GLOMUS TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
156 | GPONCO046 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : LACRIMAL GLAND TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
157 | GPONCO045 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : INFANTILE FIBROSARCOMA 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
158 | GPONCO044 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : HEPATOBILIARY CANCER / CHOLANGIO CARCINOMA 21 Genes / SNPs, Ins /Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
159 | GPONCO043 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : HEAD AND NECK CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
160 | GPONCO042 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : GESTATIONAL TROPHOBLASTIC DISEASE 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
161 | GPONCO041 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : GERM CELL TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
162 | GPONCO040 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : EMBRYONAL TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
163 | GPONCO039 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : CLEAR CELL SARCOMA OF KIDNEY 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
164 | GPONCO038 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : CHOROID PLEXUS TUMOR 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
165 | GPONCO037 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - CERVICAL CANCER 16 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
166 | GPONCO036 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - CENTRAL NERVOUS SYSTEM CANCER 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
167 | GPONCO035 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP : CANCER OF UNKNOWN PRIMARY 9 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
168 | GPONCO034 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - BONE CANCER 9 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
169 | GPONCO033 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - APPENDICEAL CANCER 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
170 | GPONCO032 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - ANGIOMATOID FIBROUS HISTIOCYTOMA 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
171 | GPONCO031 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - ANAL CANCER 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
172 | GPONCO030 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - AMPULLARY CANCER 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
173 | GPONCO029 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP - SOLID TUMORS PANEL 121 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
174 | GPONCO028 | ONCOLOGY BASED NGS | NGS | ONCORx CSP - ADENOCARCINOMA In Situ 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
175 | GPONCO027 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: UTERINE SARCOMA PANEL 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
176 | GPONCO026 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: SARCOMA PANEL 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
177 | GPONCO025 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: ESOPHAGOGASTRIC CANCER PANEL 22 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
178 | GPONCO024 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: ENDOMETRIAL CANCER PANEL 12 Genes / SNPs, Ins / Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
179 | GPONCO023 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: THYROID CANCER PANEL 22 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
180 | GPONCO022 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: GLIOMA PANEL 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
181 | GPONCO021 | ONCOLOGY BASED NGS | NGS | GASTROINTESTINAL NEUROENDOCRINE TUMOR of the Esophagus/Stomach - 21 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
182 | GPONCO020 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: BLADDER CANCER PANEL 11 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
183 | GPONCO019 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: MELANOMA PANEL 26 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
184 | GPONCO018 | ONCOLOGY BASED NGS | NGS | ONCORx CSP BREAST CANCER PANEL 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
185 | GPONCO017 | ONCOLOGY BASED NGS | NGS | ONCORx CSP NON - SMALL CELL LUNG (NSCL) CANCER PANEL 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
186 | GPONCO016 | ONCOLOGY BASED NGS | NGS | ONCORx Condition Specific Panel PROSTATE CANCER 38 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
187 | GPONCO015 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: OVARIAN CANCER PANEL 25 Genes / SNPs, InDels, CNVs, Rearrangements | FFPE TISSUE | DAILY | 21 days |
188 | GPONCO014 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: COLORECTAL CANCER – Liquid Biopsy 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | 20 mL WB In DNA streck tube | DAILY | 21 days |
189 | GPONCO013 | ONCOLOGY BASED NGS | NGS | ONCORx – CSP: OVARIAN CANCER – Liquid Biopsy 25 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | 20 mL WB In DNA streck tube | DAILY | 21 days |
190 | GPONCO012 | ONCOLOGY BASED NGS | NGS | ONCORx CSP BREAST CANCER PANEL Liquid Biopsy 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | 20 mL WB In DNA streck tube | DAILY | 21 days |
191 | GPONCO011 | ONCOLOGY BASED NGS | NGS | ONCORx CSP NON - SMALL CELL LUNG CANCER PANEL– Liquid Biopsy 27 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | 20 mL WB In DNA streck tube | DAILY | 21 days |
192 | GPONCO010 | ONCOLOGY BASED NGS | NGS | ONCORx CSP PROSTATE CANCER PANEL – Liquid Biopsy 38 Genes / SNPs, Ins/Dels, CNVs, Rearrangements | 20 mL WB In DNA streck tube | DAILY | 21 days |
193 | GPONCO009 | ONCOLOGY BASED NGS | NGS | ONCO Rx MINI - 121 Genes | FFPE TISSUE | DAILY | 21 days |
194 | GPONCO008 | ONCOLOGY BASED NGS | NGS | ONCORx COMPREHENSIVE OVARIAN CANCER 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearrangements 13 genes Ful | FFPE TISSUE & WB-EDTA | DAILY | 21 days |
195 | GPONCO007 | ONCOLOGY BASED NGS | NGS | ONCORx COMPREHENSIVE - COLORECTAL CANCER 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearrangements 13 gene | FFPE TISSUE & WB-EDTA | DAILY | 21 days |
196 | GPONCO006 | ONCOLOGY BASED NGS | NGS | ONCORx COMPREHENSIVE BREAST CANCER 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearrangements 13 genes Ful | FFPE TISSUE & WB-EDTA | DAILY | 21 days |
197 | GPONCO005 | ONCOLOGY BASED NGS | NGS | ONCORx COMPREHENSIVE NON - SMALL CELL LUNG CANCER (SCLC) 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearra | FFPE TISSUE & WB-EDTA | DAILY | 21 days |
198 | GPONCO004 | ONCOLOGY BASED NGS | NGS | ONCORx COMPREHENSIVE - PROSTATE CANCER 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearrangements 13 genes | FFPE TISSUE & WB-EDTA | DAILY | 21 |
199 | GPONCO003 | ONCOLOGY BASED NGS | NGS | ONCO Rx COMPREHENSIVE - 351 gene SNP's, InDels 260 genes for CNA's 16 genes for Rearrangements 13 genes Full footprint | FFPE TISSUE & WB-EDTA | DAILY | 21 days |
200 | GPONCO002 | ONCOLOGY BASED NGS | NGS | ONCORx EXTENSIVE COMPREHENSIVE GENOMIC PROFILING (CGP) PANEL 679 Genes, DNA + RNA Panel. Somatic | FFPE TISSUE | DAILY | 21 DAYS |
201 | GPONCO001 | ONCOLOGY BASED NGS | NGS | CANCERGUARD PGx - Breast Cancer Recurrence Risk Assessment by QPCR Somatic muta | FFPE TISSUE & WB-EDTA | DAILY | 21 DAYS |
202 | GPNGS029 | WHOLE EXOME SEQUENCING | SANGERS | GENEPOWER - LHON (Leber Hereditary Optic Neuropathy 3 GENES / SNPs, InDels | WB in EDTA | DAILY | 7 DAYS |
203 | GPNGS028 | WHOLE EXOME SEQUENCING | SANGERS | GENEPOWER - GILBERTS SYNDROME UGT1A1*28 ; UGT1A1*6 ; UGT1A1*7 Variants | WB in EDTA | DAILY | 7 DAYS |
204 | GPNGS027 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER -- PAKINSON'S RISK ASSESSMENT Essential, Resting, Postural trem | WB in EDTA | DAILY | 21 DAYS |
205 | GPNGS026 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - DEMENTIA RISK ASSESSMENT 44 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
206 | GPNGS025 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER -- RENAL STONE RISK ASSESSMENT - 16 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
207 | GPNGS024 | WHOLE EXOME SEQUENCING | SANGERS | GENEPOWER -- TACROLIUMUS Metabolism / Response Prediction CYP3A5 Variants as per CPIC Guidelines 4 GENES / SNPs, | WB in EDTA | DAILY | 7 DAYS |
208 | GPNGS023 | WHOLE EXOME SEQUENCING | SNAGERS SEQ | GENEPOWER CLOPIDOGREL Metabolism/Response Prediction CYP2C19 Variants as per CPIC Guidelines 4 GENES / SNPs, InDe | WB in EDTA | DAILY | 7 DAYS |
209 | GPNGS022 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER FATIGUE of Unknown Origin -204 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
210 | GPNGS021 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER EYE & EAR DISORDERS Early-onset retinal dyst | WB in EDTA | DAILY | 21 DAYS |
211 | GPNGS020 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER SKIN HEALTH Acne, Skin pigmentation, Collagen formation, Psoriasis, Obesity, Hirsutism, Unwanted hair grow | WB in EDTA | DAILY | 21 DAYS |
212 | GPNGS019 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - OSTEOHEALTH Degenerative Disc Disease, Degenerative Disc Disease, Cartilage degeneration, Osteoporosis, | WB in EDTA | DAILY | 21 DAYS |
213 | GPNGS018 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - PANCREATIC DISORDERS 20 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
214 | GPNGS017 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - Predisposition to Disorders of the Lung 117 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
215 | GPNGS016 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - Predisposition to Liver Disorders 77 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
216 | GPNGS015 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER -- Bleeding Disorders & Predisposition to Blood clots- Thrombophilia - 52 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
217 | GPNGS014 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - Psychiatry & Pharmacogenomics - 60 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
218 | GPNGS013 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER _ REPRODUCTIVE HEALTH MTHFR gene mutations/Folic acid deficiency predispositi | WB in EDTA | DAILY | 21 DAYS |
219 | GPNGS012 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER _ NEUROMUSCULAR HEALTH Muscular Dystrophy/ Atrophy, Dystonias, Ataxias, Parkinson’s Disease, Exercise ind | WB in EDTA | DAILY | 21 DAYS |
220 | GPNGS011 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER _CARDIAC CARE Coronary artery disease risk, Hypertrophic cardiomyopathy risk, Arrhythmia, Brugada Syndrome | WB in EDTA | DAILY | 21 DAYS |
221 | GPNGS010 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER _PEDIA HEALTH Metabolic Disorders, Endocrine Disorders, Neuromuscular Disorders, Gastrointestinal, liver an | WB in EDTA | DAILY | 21 DAYS |
222 | GPNGS009 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER _ EPILEPSY & SEIZURES Generalized Tonic Clonic Seizures, Myoclonic Seizures, Absence seizures, Partial/ Foc | WB in EDTA | DAILY | 21 DAYS |
223 | GPNGS008 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER Rx _ METABLIC DISORDERS Screening and Management ( Includes Diabetes, Hypertension, Thyroid, Obesity, Choles | WB in EDTA | DAILY | 21 DAYS |
224 | GPNGS007 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER FITESS GENOMICS Muscle/Joint/Connective Tissues, Immunity Fitness, Other Rare Myothapies, Metabolic disorder | WB in EDTA | DAILY | 21 DAYS |
225 | GPNGS006 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - NUTRIGENOMICS & METABOLISM : Carbohydrate Metabolism, Lipid Metabolism, Protein Metabolism, Vitamin metab | WB in EDTA | DAILY | 21 DAYS |
226 | GPNGS005 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - RENAL RISK SCREENING / NEPHROCARE 1. Glomerular Diseases Diabetic kidney disease Focal segmental glomer | WB in EDTA | DAILY | 21 DAYS |
227 | GPNGS004 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - HYPERTENSION RISK & MANAGEMENT | WB in EDTA | DAILY | 21 DAYS |
228 | GPNGS003 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER - DIABETES RISK & MANAGEMENT / DIABETES CARE: Predisposition for diabetes - Type 1, Type 2, Maturity o | WB in EDTA | DAILY | 21 DAYS |
229 | GPNGS002 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER PHARMACOGENOMCS : Genomic Response to the medications is assessed. Antiplatelet Agents, Anticoagulants, Ant | WB in EDTA | DAILY | 21 DAYS |
230 | GPNGS001 | WHOLE EXOME SEQUENCING | NGS | GENEPOWER TOTAL 22,000 GENES / SNPs, InDels | WB in EDTA | DAILY | 21 DAYS |
231 | BGSNG60 | SANGERS SEQUENCING | Sangers | Thiopurine Methyltransferase (TPMT - *2, *3A, *3B, *3C) Genotyping | Peripheral blood | DAILY | 5-7 days |
232 | BGSNG59 | SANGERS SEQUENCING | Targeted mutation Analysis (more than 2 mutations) | Peripheral blood/Amniotic fluid / Cord Blood/Chorionic villi | - | 10-15 days | |
233 | BGSNG58 | SANGERS SEQUENCING | Targeted mutation Analysis (2 mutations) | Peripheral blood/Amniotic fluid / Cord Blood/Chorionic villi | - | 10-15 days | |
234 | BGSNG57 | SANGERS SEQUENCING | Targeted mutation Analysis (1 mutation) | Peripheral blood/Amniotic fluid / Cord Blood/Chorionic villi | - | 10-15 days | |
235 | BGSNG56 | SANGERS SEQUENCING | Solid tumor Combo1 [EGFR,ALK1,ROS1,MET,PD L1] | Tumor tissue | - | 5-7 days | |
236 | BGSNG55 | SANGERS SEQUENCING | SANGER SEQUENCING | QF PCR Panel [13,18,21,XY] + MCC | Amniotic fluid / Chorionic villi/ Cord Blood | - | 7 days |
237 | BGSNG54 | SANGERS SEQUENCING | Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) | Trophectoderm | - | 15-20 days | |
238 | BGSNG53 | SANGERS SEQUENCING | Pre-implantation Genetic Disorder/PGD (Single Embryo) with maternal DNA contamination check | Trophectoderm + EDTA blood of mother for MCC | - | 15-20 days | |
239 | BGSNG52 | SANGERS SEQUENCING | Pre-implantation Genetic Disorder/PGD (Single Embryo- 1 mutation) | Trophectoderm | - | 15-20 days | |
240 | BGSNG51 | SANGERS SEQUENCING | Pre-implantation Genetic Disorder/PGD (Single gene Disorder- Known mutation)- Baseline | Peripheral blood of parents and affected child | - | 15-20 days | |
241 | BGSNG50 | SANGERS SEQUENCING | SANGERS SEQUENCING | POLE gene Mutation Analysis | FFPE | - | 7-8 days |
242 | BGSNG49 | SANGERS SEQUENCING | PIK3CA Mutation Analysis (Exon 7, 9 & 20) | Tumor tissue | - | 7-8 days | |
243 | BGSNG48 | SANGERS SEQUENCING | NRAS Mutation Analysis (codons 12 & 13) | Tumor tissue | - | 7-8 days | |
244 | BGSNG47 | SANGERS SEQUENCING | NPM1 Mutation Analysis (Exon 12 insertion) | Bone Marrow/Peripheral Blood | - | 7-8 days | |
245 | BGSNG46 | SANGERS SEQUENCING | SANGERS | NUDT15 gene Mutation analysis | Peripheral Blood | DAILY | 7-8 days |
246 | BGSNG45 | SANGERS SEQUENCING | Myeloproliferative Leukemia Mutation Screening (MPL - S505N; W515L) | Bone marrow / Peripheral blood | - | 7-8 days | |
247 | BGSNG44 | SANGERS SEQUENCING | MYD88 gene Mutation | Peripheral blood/Tumor tissue | - | 5-7 days | |
248 | BGSNG43 | SANGERS SEQUENCING | Microsatellite Instability (MSI) (Lynch Syndrome/Colorectal Cancer) | Peripheral blood | - | 7-8 days | |
249 | BGSNG42 | SANGERS SEQUENCING | MECP2 Full Gene Mutation Analysis (RETT Syndrome) | Peripheral blood | - | 8-10 days | |
250 | BGSNG41 | SANGERS SEQUENCING | KRAS Mutation Screening (Codons 12 & 13) | Tumor tissue | - | 7-8 days | |
251 | BGSNG40 | SANGERS SEQUENCING | Jak 2 Mutation Detection Panel (Exons 12) | Bone Marrow/Peripheral Blood | - | 7-8 days | |
252 | BGSNG39 | SANGERS SEQUENCING | Jak2 Mutation Detection Panel (Exons 12-15) | Bone marrow / Peripheral blood | - | 7-8 days | |
253 | BGSNG38 | SANGERS SEQUENCING | Irnotecan Toxicity Assessment | Peripheral Blood | - | 7-8 days | |
254 | BGSNG37 | SANGERS SEQUENCING | IGHV Mutation load | Bone marrow / Peripheral blood | - | 7-8 days | |
255 | BGSNG36 | SANGERS SEQUENCING | IDH1 & IDH2 Mutation Analysis | Tumor tissue | - | 7-8 days | |
256 | BGSNG35 | SANGERS SEQUENCING | Human Papilloma Virus - HPV16, 18 & HIGH RISK GENEOTYPES | Cervical swab | - | 7-8 days | |
257 | BGSNG34 | SANGERS SEQUENCING | Human Inmmuno-defecincy Virus - 1 (HIV-1) Drug Resistance Genotype | Peripheral blood/Plasma/Serum | - | 20-21 days | |
258 | BGSNG33 | SANGERS SEQUENCING | HLA-B*57:01 Genotyping (for Abacavir Hypersensitivity) | Peripheral blood | - | 7-8 days | |
259 | BGSNG32 | SANGERS SEQUENCING | HLA-DRB1*1501 Genotyping (Multiple Sclerosis) | Peripheral blood | - | 7-8 days | |
260 | BGSNG31 | SANGERS SEQUENCING | HLA-B*1502 Genotyping (Carbamazepine) | Peripheral blood | - | 7-10 days | |
261 | BGSNG30 | SANGERS SEQUENCING | Hepatitis C Virus (HCV) Genotype | Peripheral blood/Plasma | - | 20-21 days | |
262 | BGSNG29 | SANGERS SEQUENCING | Hepatitis B Virus (HBV) Genotype | Peripheral blood/Plasma | - | 7-8 days | |
263 | BGSNG28 | SANGERS SEQUENCING | Hemochromatosis HFE Full | Peripheral blood | - | 4-6 weeks | |
264 | BGSNG27 | SANGERS SEQUENCING | Hemochromatosis Common Mutation Analysis in HFE Gene (H63D, S61C & C282Y) | Peripheral blood | - | 7-10 days | |
265 | BGSNG26 | SANGERS SEQUENCING | GATA2 Full length gene sequencing (Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, AML) | Bone Marrow/Peripheral Blood | - | 15 days | |
266 | BGSNG25 | SANGERS SEQUENCING | GATA1 Full length gene sequencing | Bone Marrow/Peripheral Blood | - | 15 days | |
267 | BGSNG24 | SANGERS SEQUENCING | 5-Flurouracil (5-FU) Toxicity and Chemotherapeutic Response (DPYD variants) | Peripheral blood | - | 3-4 days | |
268 | BGSNG23 | SANGERS SEQUENCING | Erythropoetin receptor gene Mutation Analysis | Peripheral blood | - | 7-8 days | |
269 | BGSNG22 | SANGERS SEQUENCING | Fragile X (FMR1) Carrier Screening | Peripheral blood | - | 8-10 days | |
270 | BGSNG21 | SANGERS SEQUENCING | Epidermal Growth Factor Receptor Mutation Analysis (EGFR - Exon 18, 19, 20, 21) | Tumor tissue | - | 3-4 days | |
271 | BGSNG20 | SANGERS SEQUENCING | DMD carrier screening (79 Exons) | Peripheral blood | - | 7-10 days | |
272 | BGSNG19 | SANGERS SEQUENCING | CXCR4 gene Mutation | Peripheral Blood | - | 7-8 days | |
273 | BGSNG18 | SANGERS SEQUENCING | Cytochrome P450 2C19 Genotyping (CYP2C19) Clopidogrel resistance (*2,*3,*4,*10) | Peripheral blood | - | 7-8 days | |
274 | BGSNG17 | SANGERS SEQUENCING | Cytochrome P450 2D6 Genotyping (CYP2D6 - Alleles) | Peripheral blood | - | 7-8 days | |
275 | BGSNG16 | SANGERS SEQUENCING | SANGER SEQUENCING | Cystic Fibrosis mutation screening (CFTR - Del 508 ) | Peripheral blood | - | 7-8 days |
276 | BGSNG15 | SANGERS SEQUENCING | Cystic Fibrosis mutation screening (CFTR - Del 508)[Prenatal ] | Amniotic fluid / Chorionic villi / Cord blood +EDTA blood of mother | - | 7-8 days | |
277 | BGSNG14 | SANGERS SEQUENCING | Criggler Najjar Syndrome | Peripheral Blood | - | 7-8 days | |
278 | BGSNG13 | SANGERS SEQUENCING | Colorectal Cancer Panel [NRAS,KRAS,BRAF] | Tumor tissue | - | 7-8 days | |
279 | BGSNG12 | SANGERS SEQUENCING | Chronic Neutrophilic Leukemia (CNL)(CSF3R gene exon 14 & 17; SETBP gene - exon 4) | Bone Marrow/Peripheral Blood | - | 7-8 days | |
280 | BGSNG11 | SANGERS SEQUENCING | cKIT Mutation Screening (Exons 9, 11, 13, 17) AML | Peripheral blood | - | 7-8 days | |
281 | BGSNG10 | SANGERS SEQUENCING | CEBPA Full Gene Mutation | Peripheral Blood | - | 5-6 days | |
282 | BGSNG09 | SANGERS SEQUENCING | CALR Mutation Analysis (Deletion or Insertion in Exon 9) | Bone Marrow/Peripheral Blood | - | 7-8 days | |
283 | BGSNG08 | SANGERS SEQUENCING | BRAF Mutation Analysis (V600E) | Tumor tissue | - | 7-8 days | |
284 | BGSNG07 | SANGERS SEQUENCING | Beta Thalassemia-HBB Full Gene Analysis (Couple + Prenatal) [TRIO ANALYSIS] | Amniotic fluid / Chorionic villi / Cord blood + WB -EDTA of parents | - | 8-10 days | |
285 | BGSNG06 | SANGERS SEQUENCING | Beta Thalassemia-HBB Full gne - Couple | Peripheral blood | - | 8-10 days | |
286 | BGSNG05 | SANGERS SEQUENCING | Beta Thalassemia-HBB Full gne - Single | Peripheral blood | - | 8-10 days | |
287 | BGSNG04 | SANGERS SEQUENCING | BCR-ABL1 Kinase Domain Mutations (IRMA) | Bone marrow / Peripheral blood | - | 20-21 days | |
288 | BGSNG03 | SANGERS SEQUENCING | AML Extended Panel (BCR/ABL,AML/ETO, CBFB, PML/RARA, FLT3, NPM1, CEBPA) | Bone marrow / Peripheral blood | - | 7-8 days | |
289 | BGSNG02 | SANGERS SEQUENCING | Achondroplasia (FGFR3 full gene sequence analysis) | Peripheral blood/Amniotic Fluid/ Chorionic villi/ Cord blood | - | 2-3 weeks | |
290 | BGSNG01 | SANGERS SEQUENCING | Sangers | Achondroplasia Mutation Analysis (FGFR3 gene G1138A, G1138C) | Peipheral blood | DAILY | 10-12 days |
291 | BGGN422 | Routine Markers/Panels | BIOCHEMISTRY | HOMA - IR (Homeostatic Model Assessment for Insulin Resistance) | Fasting SERUM, Fasting Plasma Flouride | DAILY | 24 HRS |
292 | BGPCR912 | Molecular | Real Time PCR | SYPHILIS DNA PCR (Treponema pallidum ) DNA qualitative | Urethral swab, Vaginal swab, Urine, Body Fluids | DAILY | 2 DAYS |
293 | BGPCRIHC911 | Molecular | PCR Seq & IHC | EGFR Mutations + ALK + ROS | FFPE Tissue Block | DAILY | 6 DAYS |
294 | BGGN421 | Routine Markers/Panels | CULTURE | FUNGAL CULTURE FOR HYPHAE | URINE 5 ml | DAILY | 2 DAYS |
295 | BGGN420 | Routine Markers/Panels | EIA | IMMUNOGLOBULIN G SUB CLASS 4(IgG4) | Serum (2 mL) | DAILY | 2 DAYS |
296 | BGPCR884B | Molecular | Real Time PCR | BACTERIAL MENINGITIS PANEL | CSF | DAILY | 2 DAYS |
297 | BGPCR910 | Molecular | Sangers Sequencing | HLA-B*58:01 GENTYPE - ALLOPURINL SENSITIVITY | WB EDTA | DAILY | 7 DAYS |
298 | BGGN220A | Routine Markers/Panels | Clinical Electrophresis | URINE IMMUNOFIXATION ELECTOPHORESIS | Urine 5mL from 24hrs | DAILY | 2 DAYS |
299 | BGPCR909 | Molecular | LUMINEX | HLA B5 (51/52), DISEASE ASSOCIATION - Behcet’s disease | WB EDTA (2.0 mL) | DAILY | 4 days |
300 | BGGN262A | Routine Markers/Panels | EIA | METANEPHRINES, RANDOM URINE | Urine 5 mL Random | DAILY | 1 DAY |
301 | BGGN418 | Routine Markers/Panels | CLOTTING | FACTOR XIII FUNCTIONAL | PLASMA CITRATE | DAILY | 2 DAYS |
302 | BGPCR822A | Molecular | Real Time PCR | Epstein Barr Virus (EBV) Quantitative | Plasma, Serum, Body Fluids | DAILY | 2 DAYS |
303 | BGGN417 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
304 | BGFL902A | Flowcytometry | FLOWCYTOMETRY | ACUTE LEUKAEMIA (AML) PANEL : B & T CELL, MYELOID, MONOCYTIC &CYTOPLASMIC MARKERS | WB, BM in K2 EDTA & Na Heparin | DAILY | 2 DAYS |
305 | BGPCR908 | Molecular | REAL TIME PCR | Japanese Encephalitis Virus (JEV) QUALITATIVE PCR | BODY FLUIDS, SERUM | DAILY | 2 DAYS |
306 | BGGN075A | Routine Markers/Panels | CLIA | b-Human Chorionic Gonodotropin Hormone (b-HCG) Cancer marker | SERUM | DAILY | 1 DAY |
307 | BGPCR818A | Molecular | REAL TIME PCR | CYSTIC FIBROSIS (8 MUTATIONS) | WB - EDTA | DAILY | 2 DAYS |
308 | BGPCR907 | Molecular | Real Time PCR | INFLUENZA VIRAL PCR PANEL - Influenza A Subtypes, Influenza B, RSV A & B | Oro / Naso pharyngeal Sab | DAILY | 2 DAY |
309 | BGPCR906 | Molecular | Sangers Sequencing | PIC3CA MUTATION ANALYSIS (EXONS 7, 9, 20) | FFPE Tissue Block | DAILY | 8 days |
310 | BGPCR905 | Molecular | Real Time PCR | ADENOVIRUS PCR QUANTITATIVE | Plasma, Body Fluids | DAILY | 2 DAYS |
311 | BGGN416 | Routine Markers/Panels | ELISA | FILARIA ANTIBODY IgG, ELISA | SERUM | DAILY | 3 DAYS |
312 | BGGNP068 | Routine Markers/Panels | Hematology, Biochemistry, Immunology | Dr KUTIKUPPLA Health profile 1 - CBP, ESR, RBS, Urea, Creatinine, Electrolytes, TFT, LFT, Lipid Profile | Whole Blood, Serum, | DAILY | 1 DAY |
313 | BGGN419 | Routine Markers/Panels | BIOCHEMISTRY | CHOLESTROL TOTAL | SERUM | DAILY | 24 Hours |
314 | BGPCR904 | Molecular | NGS | Hereditary Pancreatitis Panel | Whole Blood in K2 - EDTA | DAILY | 28 DAYS |
315 | BGPCR903 | Molecular | REAL TIME PCR | GONORRHOEAE DNA PCR QUALITATIVE | URINE | DAILY | 2 DAYS |
316 | BGGN415 | Routine Markers/Panels | IFA | PNEUMOCYSTIS | SPUTUM, BAL FLUID, BRONCHIAL WASH | DAILY | 4 DAYS |
317 | BGPCR902 | Molecular | real time PCR | JC/BK VIRUS DNA QUANTITATIVE PCR | Blood in EDTA , Body Fluids | DAILY | 2 DAYS |
318 | BGGNP067 | Routine Markers/Panels | Hematology, Biochemistry, Immunology | HEALTH PROFILE - 1 CBP, ESR, HBA1C, LFT, KFT, TFT, Caicium, Iron Profile, Copper, | Blood in EDTA, Serum, | DAILY | 1 DAY |
319 | BGPCR901 | Molecular | real time PCR | RESPIRATORY VIRAL AND BACTERIAL [PANEL | ORO & NASO Pharyngial Swabs | DAILY | 2 DAYS |
320 | BGPCR900 | Molecular | real time PC | Bone Marrow Transplant (BMT) followup viral screening Panel - AdV, CMV, EBV, BK Virus, Parvo virus B19 | Blood in EDTA, Body Fluids | DAILY | 3 DAYS |
321 | BGGNP066 | Routine Markers/Panels | Hematology, Biochemistry, Immunology | SURGICAL PROFILE - MINOR (CBP, ABO, RBS, Viral Screening, PT INR, CT BT) | Blood in EDTA, Citrate & Fluoride and Serum | DAILY | 1 DAY |
322 | BGGNP065 | Routine Markers/Panels | Hematology, Biochemistry, Immunology | SURGICAL PROFILE - MAJOR (CBP, CUE, ABO, Electrolyes, RBS, Urea, Creatinine, Viral Screening, PT INR, CT, BT) | Blood in EDTA, Citrate & Fluoride and Serum | DAILY | 1 DAY |
323 | BGGNP063 | Routine Markers/Panels | CLIA | TORCH PROFILE (8 Parameters) - Toxoplama, Rubella, CMV, HSV 1 & 2 IgG & IgM | SERUM | DAILY | 1 DAY |
324 | BGFH737 | Cytogenetics | FISH | FISH - IRF / MUM1 | FFPE TISSUE | DAILY | 10 DAYS |
325 | BGGN414 | Routine Markers/Panels | BIOCHEMISTRY | SGOT & SGPT | SERUM | DAILY | 24 HRS |
326 | BGGN413 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
327 | BGGN412 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
328 | BGPCR899 | Molecular | MICROARRY | CHROMOSOMAL MICROARRAY - LOW RESOLUTION 315k | Whole Blood in K2 - EDTA | WEEKLY | 10 DAYS |
329 | BGGNP062 | Routine Markers/Panels | EIA | ENA (Extractable Nuclear Antigen) Profile | SERUM | DAILY | 6 DAYS |
330 | BGPCR898 | Molecular | Real Time PCR | COVID-19 RT PCR TATA OMISURE | Oro / Naso pharyngeal swab in VTM | DAILY | 1 Day |
331 | BGFL922 | Flowcytometry | FLOWCYTOMETRY | HAIRY CELL LEUKEMIA (HCL) Panel | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | DAILY | 2 DAYS |
332 | BGFL921 | Flowcytometry | FLOWCYTOMETRY | AUTOIMMUNE LYMPHO PROLIFERATIVE SYNDROME (ALPS) Panel | Whole Blood in K2 – EDTA | DAILY | 2 DAYS |
333 | BGFL920 | Flowcytometry | FLOWCYTOMETRY | CHRONIC GRANULOMATOUS DISEASE (CGD) Panel | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | DAILY | 2 DAYS |
334 | BGFL919 | Flowcytometry | FLOWCYTOMETRY | LEUCOCYTE ADHESION DEFICIENCY (LAD) Panel - | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | DAILY | 2 DAYS |
335 | BGFL918 | Flowcytometry | FLOWCYTOMETRY | FLOW LIMITED MARKERS - 4 | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | DAILY | 2 DAYS |
336 | BGGN410 | Routine Markers/Panels | CLIA | COVID 19 Spike Protein Antibody IgG (SARS-CoV2 S IgG) | SERUM | DAILY | 1 DAY |
337 | BGPCR897 | Molecular | Real Time PCR | BRUCELLA DNA PCR QUALITATIVE | SERUM, BODY FLUIDS | DAILY | 2 DAYS |
338 | BGGN236 | Routine Markers/Panels | NEPHLOMETRY | KAPPA - Serum Free Light Chain | SERUM (2 mL) | DAILY | 24 hrs |
339 | BGGN409 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
340 | BGGN408 | Routine Markers/Panels | Lateral Flow Chromatography | COVID - 19 ANTIGEN TEST ON NASAL SWAB | NASOPHARYNGEAL SWAB | DAILY | 8 Hrs |
341 | BGPCR896 | Molecular | Real Time PCR | LEPTOSPIRA DNA QUALITATIVE | Plasma, Serum, Body fluids | DAILY | 2 DAYS |
342 | BGGN407 | Routine Markers/Panels | ELISA | COVID - 19 Antibody IgG &IgM | SERUM | DAILY | 24 hrs |
343 | BGGN406 | Routine Markers/Panels | IMMUNOFLOURESCENCE ASSAY | ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM | SERUM | DAILY | 7 DAYS |
344 | BGPCR895 | Molecular | Real Time PCR | COVID -19 ( 2019 nCOV) QUAL rt PCR Confirmatory Test - N, E & RdRP genes | Oro / Naso pharyngeal swab in VTM | DAILY | 1 DAY |
345 | BGHP341 | HPE & IHC | IHC | MSI IHC PANEL - MLH1, MSH2, MSH6, PMS2 | FFPE TISSUE BLOCK | DAILY | 6 DAYS |
346 | BGGN405 | Routine Markers/Panels | MICROSCOPY | CYTOLOGY - FLUID EXAMINATION | BODY FLUID | DAILY | 1 DAY |
347 | BGPCR894 | Molecular | real time PCR | H1N1 SWINE FLU QUALITATIVE | NASAL SWAB | DAILY | 2 DAYS |
348 | BGGN438 | Routine Markers/Panels | HAEMATOLOGY + MICROSCOPY | RETICULOCYTE COUNT | WB-EDTA | DAILY | 24 HRS |
349 | BGGN404 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
350 | BGGN403 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
351 | BGSNG69 | SANGERS SEQUENCING | Sangers | C KIT MUTATIONS - EXONS 9,11, 13, 17 | WB EDTA | DAILY | 5 DAYS |
352 | BGGN402 | Routine Markers/Panels | MICROSCOPY AND CHEMICAL METHOD | STOOL EXAMINATION | STOOL (2 g ) | DAILY | 1 DAY |
353 | BGPCR892 | Molecular | Real TIme PCR | HSV (Herpes Simplex Virus) 1 & 2 QUANT PCR | CSF, Plasma, Serum, Body Fluids | DAILY | 2 DAYS |
354 | BGGN401 | Routine Markers/Panels | ELISA | ALDOSTERONE - PLASMA RENIN ACTIVITY RATIO | WB-PLASMA & SERUM 2ml | DAILY | 2 DAYS |
355 | BGGN400 | Routine Markers/Panels | EIA | Free-Androgen Index | SERUM | DAILY | 24 HRS |
356 | BGGN399 | Routine Markers/Panels | ELISA | VIRAL SCREENING (HBsAG Anti HCV & HIV 1&2) | Plasma EDTA / SERUM 2ml | DAILY | 24 HRS |
357 | BGGN398 | Routine Markers/Panels | BIOCHEMISTRY | CT, BT (CLOTTING TIME BLEEDING TIME) | WB-CITARATE 2ml | DAILY | 24 HRS |
358 | BGFH736 | Cytogenetics | FISH | LEUKEMIA /LIMPHOMA INDIVIDUAL FISH MARKER | WB/BM in HEPARIN | DAILY | 5 DAYS |
359 | BGPCR891 | Molecular | Real Time PCR | DENGUE VIRUS RNA PCR QUALITATIVE | Serum, Body Fluid | DAIL | 4 DAYS |
360 | BGKY606 | Cytogenetics | KARYOTYPING | CULTURED CELLS PBMC | Cultured WB/BM cells | DAILY | 3 DAYS |
361 | BGGN397 | Routine Markers/Panels | MICROSCOPY | GRAM Staining | Urine, Blood, Body fluids | DAILY | 1 DAY |
362 | BGGN396 | Routine Markers/Panels | EIA | VITAMIN - K | SERUM 2mL | DAILY | 2 DAYS |
363 | BGGN395 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
364 | BGGN394 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
365 | BGGN393 | Routine Markers/Panels | EIA | NGAL ( Neutrophil Gelatinase Associated Lipocalin) | SERUM 2 mL | DAILY | 3 DAYS |
366 | BGPCR890 | Molecular | Real Time PCR | TORCH PCR PANEL - Toxoplasma, Rubella, CMV, HSV 1 & 2 | WB EDTA, Serum, Bldy Fluid | DAILY | 3 DAYS |
367 | BGHP339 | HPE & IHC | IHC | IHC MARKERS - SINGLE MARKER | FFPE TISSUE BLOCK | DAILY | 5 DAYS |
368 | BGGN392 | Routine Markers/Panels | EIA | HSV AVIDITY IgG | SERUM 2mL | DAILY | 2 DAYS |
369 | BGGN391 | Routine Markers/Panels | SPECTROPHOTOMETRY | URINE - PROTEIN CREATININE RATIO | URINE 5mL | DAILY | 24 HRS |
370 | BGGN390 | Routine Markers/Panels | SPECTROPHOTOMETRY | URINARY PROTEINS - 24 Hrs Urine | 24 Hrs URINE - 20ml | DAILY | 24 HRS |
371 | BGPCR889 | Molecular | Real Time PCR | CHIKUNGUNYA VIRUS RNA PCR QUALITATIVE | Serum 2mL, Body Fluids | DAILY | 3 DAYS |
372 | BGHP338 | HPE & IHC | IHC | IHC MARKERS - THREE MARKERS | FFPE TISSUE BLOCK | DAILY | 5 DAYS |
373 | BGHP337 | HPE & IHC | IHC | IHC MARKERS - TWO MARKERS | FFPE TISSUE BLOCK | DAILY | 5 DAYS |
374 | BGGN388 | Routine Markers/Panels | EIA | RUBELLA AVIDITY | SERUM 2mL | DAILY | 3 DAYS |
375 | BGGN387 | Routine Markers/Panels | EIA | CYTOMEGALO VIRUS AVIDITY | SERUM 2ml | DAILY | 24 HRS |
376 | BGGN386 | Routine Markers/Panels | LATERAL FLOW (RAPID) | PREGNANCY SCREEN Beta-HCG, URINE | URINE 5 mL | DAILY | 24 HRS |
377 | BGGNP061 | Routine Markers/Panels | EIA / CLIA / BIOCHEMISTRY | FEVER PROFILE - HEMOGRAM, CRP, WIDAL, MPT, DENGUE, CHIKUN GUNYA | WB EDTA, SERUM | DAILY | 1 DAY |
378 | BGGN385 | Routine Markers/Panels | HAEMOLOTOGY + MICROSCOPY | HAEMOGRAM - CBC + SLIDE MORPHOLOGY | WB-EDTA | DAILY | 24 HRS |
379 | BGGN389 | Routine Markers/Panels | FEIA | CANDIDA ALBICANS, | SERUM | DAILY | 24 HRS |
380 | BGGNP060 | Routine Markers/Panels | CLIA | Fertility Profile - V (AFP, ASAB, bHCG, DHEAS, E2, FSH, LH, Progesterone, PRL) | SERUM 2mL | DAILY | 1 DAY |
381 | BGGNP059 | Routine Markers/Panels | CLIA | Fertility Profile - IV (LH, FSH, PRL, E2, TSH) | SERUM 2mL | DAILY | 1 DAY |
382 | BGGNP058 | Routine Markers/Panels | CLIA | IN Fertility Profile - (LH, FSH, PRL, Testosterone) | SERUM 2mL | DAILY | 1 DAY |
383 | BGGNP057 | Routine Markers/Panels | CLIA | Fertility Profile - II (LH, FSH, PRL,TSH) | SERUM 2mL | DAILY | 1 DAY |
384 | BGGNP056 | Routine Markers/Panels | CLIA | Fertility Profile - I (LH, FSH, PRL) | SERUM 2mL | DAILY | 1 DAY |
385 | BGGN384 | Routine Markers/Panels | EIA | Anti-NMO (NEUROMYELITIS OPTICA) ANTIBODY / AQUAPORIN 4 (AQP4) Antibody | SERUM 2mL | DAILY | 6 DAYS |
386 | BGGN383 | Routine Markers/Panels | EIA | GAD-65 (Glutamic Acid Decarboxylase) Antibody IgG | SERUM 2mL | DAILY | 6 DAYS |
387 | BGFL917 | Flowcytometry | FLOWCYTOMETRY | FLOW LIMITED MARKERS - 2 | Whole Blood / Bone Marrow in Na- Heparin and K2 - EDTA | DAILY | 2 days |
388 | BGFL916 | Flowcytometry | FLOWCYTOMETRY | LEUKEMIA ALL / AML MRD PANEL | Bone Marrow in Na HEPARIN / K3 EDTA | DAILY | 3 DAYS |
389 | BGPCR888 | Molecular | PCR | AML PCR - AML1 / ETO - t(8;21)(q22;q22) | WB/BM in K2 EDTA | DAILY | 3 DAYS |
390 | BGPCR887 | Molecular | PCR | AML PCR - INVERSION 16 (p13;q22) CBF? (16q22) and MYH11 (16p13) | WB/BM in K2 EDTA | DAILY | 3 DAYS |
391 | BGPCR886 | Molecular | PCR & SEQUENCING | Delta 32 (CCR5 GENE ) MUTATIONS | WB EDTA | DAILY | 5 days |
392 | BGGN382 | Routine Markers/Panels | HAEMATOLOGY | ABSOLUTE EOSINPHIL COUNT | WB EDTA | DAILY | 24 HRS |
393 | BGGN381 | Routine Markers/Panels | EIA | PYRUVATE KINASE ENZYME ASSAY | SERUM 2mL | DAILY | 3 DAYS |
394 | BGGN380 | Routine Markers/Panels | CULTURE | STOOL CULTURE & SENSITIVITY | STOOL 2gr | DAILY | 2 DAYS |
395 | BGGN379 | Routine Markers/Panels | RIA / EIA | MUSK Antibody ( Muscle Specific Tyrosine Kinase Antibody) | Serum 2mL | DAILY | 7 days |
396 | BGGN378 | Routine Markers/Panels | CHROMATOGRAPHY | KETONE BODIES | 24 hrs URINE 20 mL | DAILY | 3 DAYS |
397 | BGGN377 | Routine Markers/Panels | ENZYMATIC METHOD | KETONE BODIES | SERUM 2mL | DAILY | 24 HRS |
398 | BGPCR885 | Molecular | PCR & SEQUENCING | BLANK | WB-EDTA 3mL | DAILY | 5 DAYS |
399 | BGPCR884 | Molecular | Real Time PCR | VIRAL & BACTERIA MENINGITS PCR PANEL | CSF | DAILY | 2 DAYS |
400 | BGGN376 | Routine Markers/Panels | EIA | VON WILBRAND FACTOR ANTGEN | WB - Na CITRATE 3 mL | DAILY | 10 Days |
401 | BGGN375 | Routine Markers/Panels | BIOCHEMISTRY | PYRUVIC ACID / PYRUVATE | WB in Na FLOURIDE - 3mL | DAILY | 24 HOURS |
402 | BGGNP055 | Routine Markers/Panels | ELISA | STD PANEL - VDRL, HIV 1 & 2, HSV 1 &2, Chlamydia, TPHA | SERUM, BODY FLUIDS | DAILY | 3 DAYS |
403 | BGPCR883 | Molecular | Real Time PCR | BLOOD BANK SCREENING / NAT PCR - HIV 1 & 2, HCV and HBV | Plasma EDTA / Serum - 2mL | DAILY | 48 HRS |
404 | BGGN374 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
405 | BGPCR882 | Molecular | PCR & SEQUENCING | AML PCR PANEL II - FLT3, MPM1 & C/EBPA ( WITH NORMA CYTOGENETICS) | WB / BM in K3-EDTA 4mL | DAILY | 5 DAYS |
406 | BGFH735 | Cytogenetics | FISH | MDS FISH PANEL - del 5q, del 7q, del 20q | BM / WB in Na HEPARIN | DAILY | 7 Days |
407 | BGFL915 | Flowcytometry | FLOWCYTOMETRY | KAPPA & LAMBDA LISHT CHAIN FLOW ASSAY | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | DAILY | 2 DAYS |
408 | BGGN373 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
409 | BGGN372 | Routine Markers/Panels | EIA | HE4 (Human Epididymis protein 4) Tumor Marker | SERUM | DAILY | 4 Days |
410 | BGFH734 | Cytogenetics | FISH | AML FISH PANEL - PML-RARa t(15;17), AML-M4 Eo - Inv (16), ETO/AML1 - t(8;21) + Karyotyping | BM / WB in Na HEPARIN | DAILY | 7 DAYS |
411 | BGFL914 | Flowcytometry | FLOWCYTOMETRY | MULTIPLE MYELOMA FLOW PANEL | Whole Blood / Bone Marrow in k2 EDTA / Na HEPARIN | DAILY | 2 Days |
412 | BGFH733 | Cytogenetics | FISH | ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) FISH PANEL ABL (9q34) / BCR(22q11) - t(9;22)(q34;q11) E2A(19p13) / PBX1(1q23) - t(1 | WB / BM in Na Heparin | DAILY | 7 DAYS |
413 | BGPCR881 | Molecular | RT-PCR & SEQUENCING | MPN REFLEX PANEL BCR-ABL qual, JAK2V617F, JAK2 EXON 12-15, CAL-R, MPL MUTATIONS | WB EDTA | DAILY | 7 DAYS |
414 | BGGN371 | Routine Markers/Panels | EIA | TSH RECEPTOR ANTIBODY | SERUM | DAILY | 4 DAYS |
415 | BGGNP054 | Routine Markers/Panels | Electrophoresis, Nephlometry, EIA | MULTIPLE MYELOMA PROTEIN PANEL - SPEP, IFE, KAPPA, LAMBDA, B2MG, IgA, IgM, IgA | 3 mL Serum | Daily | 4 days |
416 | BGPCR880 | Molecular | Real Time PCR | MTB ( M tuberulosis) & NTM (Non Tuberculosis Microorganisms) | 2 - 3 ml Sputum, CSF, Body fluids | DAILY | 2 DAYS |
417 | BGPCR879 | Molecular | Real Time PCR | STD - 8 Pathogens Panel - Chlamydia, Neisseria, Ureaplasma, Mycoplasma genitalium, Mycoplasma hominis, Trichomonas, HSV | Body fluids, Urine | DAILY | 2 DAYS |
418 | BGFH732 | Cytogenetics | FISH | MULTIPLE MYELOMA FISH PANEL t(4;14), t(11;14), Del(13q14), Del (17p) | BM / WB in Na HEPARIN | DAILY | 5 DAYS |
419 | BGGNP053 | Routine Markers/Panels | IMMUNOCAP | ALLERGY SCREEN- INHALENTS | SERUM | DAILY | 3 DAYS |
420 | BGGNP052 | Routine Markers/Panels | IMMUNOCAP | ALLERGY SCREEN - DRUGS | SERUM 3mL | DAILY | 3 DAYS |
421 | BGPCR878 | Molecular | PCR | PDGFR ALPHA GENE MUTATIONS | WB / BM in EDTA | DAILY | 3 DAYS |
422 | BGFH731 | Cytogenetics | FISH | CLL FISH PANEL del13q14, del 17p13, C-MYC t(8;11), del 6q21, del11q22 | WB / BM in Na Heparin | DAILY | 6 DAYS |
423 | BGGN370 | Routine Markers/Panels | GC - MS | SUCCINYL ACETONE, URINE | URINE 5mL | DAILY | 5 DAYS |
424 | BGGN369 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
425 | BGGN368 | Routine Markers/Panels | AGGLUTINATION | WIDAL | SERUM | DAILY | 24 HRS |
426 | BGGN367 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
427 | BGGN024 | Routine Markers/Panels | TLC | AMINO ACIDS | Na Heparin, CSF, Urine | DAILY | 3 Days |
428 | BGPCR877 | Molecular | real time PCR | HIV 2 RNA Qualitative | WB EDTA | DAILY | 2 DAYS |
429 | BGGN366 | Routine Markers/Panels | ELISA | HUMAN LYSOPHOTIDIC ACID | SERUM | DAILY | 2 DAYS |
430 | BGGN365 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
431 | BGGN364 | Routine Markers/Panels | IFA | STRIATED / SKELETAL MUSCLE (ASKA) Antibody | Serum (2 mL) | Daily | 3 DAYS |
432 | BGFH730 | Cytogenetics | FISH | ROS1 REARRANGEMENT | FFPE TISSUE BLOCK | DAILY | 6 DAYS |
433 | BGKY605 | Cytogenetics | KARYOTYPING | STRESS CYTOGENETICS - CHROMOSOMAL BREAKAGE STUDIES (FANCONI'S ANAEMIA) | WB / BM in HEPARIN | DAILY | 12 DAYS |
434 | BGFL913 | Flowcytometry | FLOWCYTOMETRY | Natural Killer Cell (NK) Panel (CD 3-16/56-45) | Whole Blood in Na Heparin / K2 EDTA | DAILY | 2 DAYS |
435 | BGGN363 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
436 | BGPCR876 | Molecular | PCR + SEQUENCING | TACROLIMUS GENOTYPING CYP3A5 ASSAY | WB EDTA | DAILY | 4 DAYS |
437 | BGGN362 | Routine Markers/Panels | ELISA | Anti Rabies Antibody IgM | Serum (2 mL) | Daily | 3 DAYS |
438 | BGGN361 | Routine Markers/Panels | ELISA | BETA CELL ACTIVATION FACTOR (BAF) | Serum (2 mL) | DAILY | 3 DAYS |
439 | BGGN360 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
440 | BGGN359 | Routine Markers/Panels | HEMATOLOGY | PT INR | SODIUM CITRATE | DAILY | 24 HRS |
441 | BGGN358 | Routine Markers/Panels | XXX | XXXXXXX | XXX | XXX | XXX |
442 | BGKY604 | Cytogenetics | KARYOTYPING | CHROMOSOMAL ANALYSIS - product of conception (POC) | foetal tissue in saline sterile container | Daily | 21 DAYS |
443 | BGKY603 | Cytogenetics | KARYOTYPING | CHROMOSOMAL ANALYSIS - PERIPHERAL BLOOD | PB in Na HEPARIN (2 - 4ml) | Daily | 10 DAYS |
444 | BGKY602 | Cytogenetics | KARYOTYPING | CHROMOSOMAL ANALYSIS - BONE MARROW | BM in Na HEPARIN (2 - 4ml) | Daily | 10 DAYS |
445 | BGKY601 | Cytogenetics | KARYOTYPING | CHROMOSOMAL ANALYSIS - AMNIOTIC FLUID | 20 – 30 ml Amniotic Fluid | Daily | 21 DAYS |
446 | BGFH729 | Cytogenetics | FISH | TRISOMY 8 (AML) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
447 | BGFH728 | Cytogenetics | FISH | TEL / AMLI - t(12;21) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
448 | BGFH727 | Cytogenetics | FISH | PDGFR – BETA (CMML) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
449 | BGFH726 | Cytogenetics | FISH | PDGFR – ALPHA (HES) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
450 | BGFH725 | Cytogenetics | FISH | PML- RARa t(15;17) - AML | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
451 | BGFH724 | Cytogenetics | FISH | Prader - Willi Syndrome SNRPN | PB in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
452 | BGFH723 | Cytogenetics | FISH | t(11;14) – Mantle Cell Lymphoma | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
453 | BGFH722 | Cytogenetics | FISH | N MYC (NEUROBLASTOMA) GENE AMPLIFICATION | FFPE tissue block | Daily | 5 DAYS |
454 | BGFH721 | Cytogenetics | FISH | MLL (11q 23) Myelod/ Lymphoid Leukemia t(4;11) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
455 | BGFH720 | Cytogenetics | FISH | Inversion 16 – AML | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
456 | BGFH719 | Cytogenetics | FISH | IgH/BCL 2 (MM) t(14:18) B-cell lymphoma panel | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
457 | BGFH718 | Cytogenetics | FISH | EWSR1 Gene Translocation (EWing Sarcoma) | FFPE tissue block | Daily | 5 DAYS |
458 | BGFH717 | Cytogenetics | FISH | E2A - t(1;19)(q23;p13) (ALL) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
459 | BGFH716 | Cytogenetics | FISH | Deletion 20q (MDS) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
460 | BGFH715 | Cytogenetics | FISH | Deletion 7q (MDS) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
461 | BGFH714 | Cytogenetics | FISH | Deletion 5q (MDS) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
462 | BGFH713 | Cytogenetics | FISH | DI GEORGE SYNDORME 22q11.2 Deletion | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 7 DAYS |
463 | BGFH712 | Cytogenetics | FISH | Deletion 13Q (MM,CLL) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 5 DAYS |
464 | BGFH711 | Cytogenetics | FISH | C MYC t(8;14) (ALL, NHL, CLL) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 7 DAYS |
465 | BGFH710 | Cytogenetics | FISH | BREAST CANCER HER-2 / NEU Gene Amplification | FFPE tissue block | Daily | 7 DAYS |
466 | BGFH709 | Cytogenetics | FISH | BCR / ABL or Philadelphia Translocation t(9:22) | PB/BM in Na HEPARIN (2 - 4ml) | Daily | 4 DAYS |
467 | BGFH708 | Cytogenetics | FISH | AMNIO / POC FISH - ( 21/18/13/X/Y) | 2 X 15mL Amniotic Fluid in sterile Tube | Daily | 4 DAYS |
468 | BGFH707 | Cytogenetics | FISH | AMNIO Three Probes (any 3 from 21/18/13/X/Y) | 2 X 15mL Amniotic Fluid in sterile Tube | Daily | 4 DAYS |
469 | BGFH706 | Cytogenetics | FISH | AMNIO Two Probes (any 2 from 21/18/13/X/Y) | 2 X 15mL Amniotic Fluid in sterile Tube | Daily | 4 DAYS |
470 | BGFH705 | Cytogenetics | FISH | AMNIO One Probes (any 1 from 21/18/13/X/Y) | 2 X 15mL Amniotic Fluid in sterile Tube | Daily | 4 DAYS |
471 | BGFH704 | Cytogenetics | FISH | 17p (p53) - MM & CLL | FFPE tissue block | Daily | 5 DAYS |
472 | BGFH703 | Cytogenetics | FISH | 11q (ATM) – MM & CLL | FFPE tissue block | Daily | 5 DAYS |
473 | BGFH702 | Cytogenetics | FISH | AML/ETO t(8;21) - AML M2 | FFPE tissue block | Daily | 5 DAYS |
474 | BGFH701 | Cytogenetics | FISH | ALK / EML4 mutations (Lung Cancer) | FFPE tissue block | Daily | 7 DAYS |
475 | BGHP336 | HPE & IHC | IHC | SARCOMA TYPING PANEL - Desmin, Vimentin, S100, SMA, CD 31, CD34 | FFPE Tissue Block | Daily | 6 DAYS |
476 | BGHP335 | HPE & IHC | IHC | Pitituary Panel - PRL, Growth Hormone, LH, PCK, Ki67 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
477 | BGHP334 | HPE & IHC | IHC | Myleoma / Plasmacytoma panel CD45 LCA, CD20, CD138, KAPPA, LAMBDA, Ki67 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
478 | BGHP333 | HPE & IHC | IHC | MSI Panel for Colorectal Carcinoma - MLH -1, MSH-2, MSH-6, PMS-2 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
479 | BGHP332 | HPE & IHC | IHC | Mesothelioma panel - Ber-EP4, CEA, Calaretin, WT1 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
480 | BGHP331 | HPE & IHC | IHC | Non Hodgkin's Lymphoma panel (NHL) LCA, CD10, CD20, PAX5, CD5, CD3, CD23, CyclinD1, BC2, OCT2, BOB1 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
481 | BGHP330 | HPE & IHC | IHC | Hodgkin's Lymphoma panel - LCA, CD30, CD15, EBV, CD20, PAX5, CD5 | FFPE TISSUE BLOCK | Daily | 7 DAYS |
482 | BGHP329 | HPE & IHC | IHC | FOLLICULAR LYMPHOMA Vs REACTIVE HYPERPLASIA - CD3, CD20, BCL-2 | FFFPE TISSUE BLOCK | Daily | 7 DAYS |
483 | BGHP328 | HPE & IHC | IHC | IHC Final Diagnostic panel - 2 (Up to 8 IHC markers) | FFPE TISSUE BLOCK | Daily | 7 DAYS |
484 | BGHP327 | HPE & IHC | IHC | IHC – Final Diagnostic panel-1 (Up to 5 markers) | FFPE TISSUE BLOCK | Daily | 6 DAYS |
485 | BGHP326 | HPE & IHC | IHC | IHC – DIFFUSE SMALL CELL LYMPHOMAPANEL CD3, CD5, CD10, CD20, CD23 | FFPE TISSUE BLOCK | Daily | 4 DAYS |
486 | BGHP325 | HPE & IHC | IHC | IHC – DIFFUSE LARGE CELL LYMPHOMA PANEL CD 3, CD45, CD20, CD30, Ki67 | FFPE TISSUE BLOCK | Daily | 4 DAYS |
487 | BGHP324 | HPE & IHC | IHC | IHC – CNS NEOPLASMS - GFAP, EMA, GFAP, SYNAPTOPHYSIN, S-100, CD3, CD20, CYTOKEATIN | FFPE TISSUE BLOCK | Daily | 4 DAYS |
488 | BGHP323 | HPE & IHC | IHC | Breast Cancer Panel 2 : ER, PR, HER2 NEU and Ki67 | FFPE TISSUE BLOCK | Daily | 4 DAYS |
489 | BGHP322 | HPE & IHC | IHC | Breast hormone panel 1 :ER, PR, HER2NEU | FFPE Tissue Block | Daily | 4 DAYS |
490 | BGHP321 | HPE & IHC | IHC | IHC – Breast hormone panel ER, PR | FFPE TISSUE BLOCK | Daily | 4 DAYS |
491 | BGHP320 | HPE & IHC | IHC | SPECIAL STAINS – Each Stain ( Reticulin, perls, PAS, Alcian Blue, GMS, Masson’s Trichome, ZN, Fite farraco, EVG) | FFPE TISSUE BLOCK | Daily | 4 DAYS |
492 | BGHP319 | HPE & IHC | IHC | IHC - INDIVIDAUL MARKERS AFP, ALK-1, BCL-2 , BCL-6, BETA CATENIN, BHCG, CALDESMON, CALRETININ, CALCITONIN, CATHEPSIN-D, | FFPE TISSUE BLOCK | Daily | 4 DAYS |
493 | BGHP318 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION slide for review (more than 4 slides) | SLIDES | Daily | 4 DAYS |
494 | BGHP317 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION slides for review (upto 4 slide) | SLIDES | Daily | 4 DAYS |
495 | BGHP316 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION slide for review (1 slide) | SLIDES | Daily | 4 DAYS |
496 | BGHP315 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION block for review (more than 4 blocks) | F F P E TISSUE BLOCK | Daily | 4 DAYS |
497 | BGHP314 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION block for review (upto 4 blocks) | F F P E TISSUE BLOCK | Daily | 4 DAYS |
498 | BGHP313 | HPE & IHC | HISTOPATHOLOGY | BIOPSY - SKIN | BIOPSY in FORMALIN | Daily | 4 DAYS |
499 | BGHP312 | HPE & IHC | HISTOPATHOLOGY | BIOPSY- RENAL | BIOPSY in FORMALIN | Daily | 4 DAYS |
500 | BGHP311 | HPE & IHC | HISTOPATHLOGY | BIOPSY- LIVER – NEEDLE | BIOPSY in FORMALIN | Daily | 4 DAYS |
501 | BGHP310 | HPE & IHC | HISTOPATHLOGY | BIOPSY- PROSTRATE – FNAC | BIOPSY in FORMALIN | Daily | 4 DAYS |
502 | BGHP309 | HPE & IHC | MICROSCOPY | BIOPSY-SECOND OPINION slide and block for review (1 block) | FFPE TISSUE/ SLIDES | Daily | 4 DAYS |
503 | BGHP308 | HPE & IHC | HISTOPATHLOGY | BIOPSY-EXTRA LARGE SPECIMEN (radical excisions for cancers) | BIOPSY in FORMALIN | Daily | 5 DAYS |
504 | BGHP307 | HPE & IHC | HISTOPATHLOGY | BIOPSY - SMALL SPECIMEN : endometrial and cervical biopsies, endoscopic biopsies, trucut biopsies, apendix, fallopian tu | BIOPSY in FORMALIN | Daily | 4 DAYS |
505 | BGHP306 | HPE & IHC | HISTOPATHLOGY | BIOPSY - MEDIUM SPECIMEN : simple hysterectomy, placenta, gal l bladder, breast lumpectomies and | BIOPSY in FORMALIN | Daily | 4 DAYS |
506 | BGHP305 | HPE & IHC | HISTOPATHOLOGY | BIOPSY - LARGE SPECIMEN: Hysterectomy with salpingo-oophorectomy, ovarian cysts, non- malignant excisions of thyroid, k | BIOPSY in FORMALIN | Daily | 4 DAYS |
507 | BGHP304 | HPE & IHC | Staining & MS | BONE MARROW smear Iron stain | 2mL Bone Marrow in EDTA | Daily | 4 DAYS |
508 | BGHP303 | HPE & IHC | HPE | BONE MARROW ASPIRATE Examination | 2mL Bone Marrow in EDTA | Daily | 4 DAYS |
509 | BGHP302 | HPE & IHC | HISTOPATHOLOGY | BONE MARROW BIOPSY | B M SPECIMEN | Daily | 4 DAYS |
510 | BGHP301 | HPE & IHC | HISTOPATHOLOGY | BIOPSY - BONE | BIOPSY in Formalin | Daily | 6 DAYS |
511 | BGGNP051 | Routine Markers/Panels | BIOCHEMISTRY | WILSON PROFILE Iron, Copper, Ferritin, Ceruloplasmin, 24hrs Urine copper | Serum & Urine | Daily | 24 hrs |
512 | BGGNP050 | Routine Markers/Panels | CLIA | THYROID PROFILE - T3/T4/TSH | SERUM (3 mL) | Daily | 24 hrs |
513 | BGGNP049 | Routine Markers/Panels | EIA | TORCH PROFILE (10 Parameters) - Toxoplama, Rubella, CMV, H | SERUM (3 mL) | Daily | 2 Days |
514 | BGGNP048 | Routine Markers/Panels | EIA | QUADRUPLE MARKER SCREEN – AFP, BETA HCG, INHIBIN & Estriol, Unconjugated (E3) | SERUM (3 mL) | Daily | 3 Days |
515 | BGGNP047 | Routine Markers/Panels | EIA | PREGNANCY SCREEHN - TRIPLE MARKER SCREEN – AFP, BETA HCG & Estriol, Unconjugated (E3) | SERUM (3 mL) | Daily | 2 Days |
516 | BGGNP046 | Routine Markers/Panels | NEPHLOMETRY & EIA | THROMBOPHILIA PROFILE – Protein C , Protein S & ANTI Thrombin III | Citrate Plasma (3 mL) | Daily | 24 hrs |
517 | BGGNP045 | Routine Markers/Panels | NEPHLOMETRY | KAPPA & LAMBDA SERUM FREE LIGHT CHAINS | SERUM (3 mL) | Daily | 24 hrs |
518 | BGGNP044 | Routine Markers/Panels | EIA / IFA | SLE PANEL – ANA, ds DNA, CRP, c3, c4, c-ANCA, p-ANCA, ESR | SERUM (3 mL) | Daily | 2 Days |
519 | BGGNP043 | Routine Markers/Panels | EIA / IFA | PHOSPHO LIPID SYNDROME PANEL CARDIOLIPN IgG & IgM, ANTI PHOSPHOLIPID IgG & IgM, LUPUS ANTI COAGULANT, BETA 2 GLYCOPROT | SERUM (3 mL) | DAILY | 1 Day |
520 | BGGNP042 | Routine Markers/Panels | EIA, BIOCHEM | PCOD PANEL Comprehensive - LH, FSH, PROLACTIN, TSH, DHEAS, AMH, TESTOSTERONE (free & | SERUM (3mL), WB- FLOURIDE | Daily | 24 hrs |
521 | BGGNP041 | Routine Markers/Panels | EIA, BIOCHEM | PCOD PANEL - LH, FSH, PROLACTIN, TESTOSTERONE (free & total) GLUCOSE FASTING, INSULIN | SERUM (3mL), WB- FLOURIDE | Daily | 24 hrs |
522 | BGGNP040 | Routine Markers/Panels | CLIA | OVARIAN RESERVE PANEL - | Na Citrate Plasma | Daily | 24 hrs |
523 | BGGNP039 | Routine Markers/Panels | FLOW | OBSTETRIC PANEL - NK | SERUM (3mL), WB- FLOURIDE | Daily | 2 Days |
524 | BGGNP038 | Routine Markers/Panels | CLIA | MENOPAUSAL SCREENING PANEL - E | WB EDTA (3 mL) | Daily | 24 hrs |
525 | BGGNP037 | Routine Markers/Panels | BIOCHEMISTRY | LIVER FUNCTION TESTS - Albumin, Bilirubin (Indirect, Direct & Total), Pr | SERUM (3 mL) | Daily | 24 hrs |
526 | BGGNP036 | Routine Markers/Panels | BIOCHEMISTRY | LIPID PROFILE - Triglycerides, HDL – Cholesterol, LDL - Cholesterol, VLDL - Cholesterol, TOTAL Cholesterol / HDL | SERUM (3 mL) | Daily | 24 hrs |
527 | BGGNP035 | Routine Markers/Panels | BIOCHEMISTRY | KIDNEY FUNCTION TESTS – Urea , Creatinine, Uric acid, Electrolytes, Protein Total, Albumin, Calcium, Phosphorus, So | SERUM (3 mL) | Daily | 24 hrs |
528 | BGGNP034 | Routine Markers/Panels | EIA | Immunoglobulin Panel - IgG, IgA, IgM, IgE | SERUM (3 mL) | Daily | 24 hrs |
529 | BGGNP033 | Routine Markers/Panels | BIOCHEMISTRY | IRON PROFILE – Iron, Ferritin, Iron binding capacity, Transferrin saturation | SERUM (3 mL) | Daily | 24 hrs |
530 | BGGNP032 | Routine Markers/Panels | CLIA | HYPOGONADISM PROFILE - LH, FSH, Estra | SERUM (3 mL) | Daily | 24 hrs |
531 | BGGNP031 | Routine Markers/Panels | Blotting lot + PCR + FLOW | HIV MONITORING – comprehensive Western Blot, CD3/CD4/CD8, HIV1 Viral Load | WB EDTA (3 mL) | Daily | 2 Days |
532 | BGGNP030 | Routine Markers/Panels | IMMUNOLOGY | VASCULITIS PROFILE - ANA, P-ANCA (MPO), C- ANCA (PR3) & ds DNA | SERUM (3 mL) | Daily | 1 Day |
533 | BGGNP029 | Routine Markers/Panels | EIA | HEPATITIS PROFILE – HAV - IgG, IgM; HEV - IgG, IgM, HBs Ag, ANTI HBs, HBe Ag, ANTI HBe Ag, HBc IgM , ANTI HCV | SERUM (2 X 3 mL) | Daily | 24 hrs |
534 | BGGNP028 | Routine Markers/Panels | CAOGULATION | HEMOPHILIA PROFILE - APTT, FACTOR VIII, FACTOR IX | Na Citrate Plasma (6mL) | Daily | 2 Days |
535 | BGGNP027 | Routine Markers/Panels | CLIA | FERTILITY PROFILE - AMH, LH, FSH, PROLACTIN TESTOSTERONE (total & free) | SERUM (3 mL) | Daily | 24 hrs |
536 | BGGNP026 | Routine Markers/Panels | BIOCHEMISTRY | ELECTROLYTES PANEL - Sodium, Potassium, Chloride | SERUM (3 mL) / URINE (10 mL) | Daily | 24 hrs |
537 | BGGNP025 | Routine Markers/Panels | CLIA/NEPHLOMETRY | DEEP VEIN THRMBOSIS PANEL (DVT PANEL) Protein C, Protein S, Antothrombin C | SERUM (3 mL), Citrated Plasma ( 3mL) | Daily | 2 Days |
538 | BGGNP024 | Routine Markers/Panels | LFI | DRUGS OF ABUSE SCREEN / URINE TOXICOLOGY Testing Opiates (e.g., heroin, morphine), Cannabinoids (marijuana/THC), C | URINE (10 mL) | Daily | 3 Days |
539 | BGGNP023 | Routine Markers/Panels | EIA | PREGNANCY SCREEN - DOUBLE MARKER SCREEN – PAPP-A, HCG (Free) | SERUM (3 mL) | Daily | 2 Days |
540 | BGGNP022 | Routine Markers/Panels | BIOCHEMISTRY | DIABETIC BASIC PROFILE – FBS, PLBS, GTT, HBA1C | WB – FLOURIDE, WB- EDTA, SERUM | Daily | 24 hrs |
541 | BGGNP021 | Routine Markers/Panels | EIA | COLLAGEN panel - ANA, dsDNA, | SERUM (3 mL) | Daily | 24 hrs |
542 | BGGNP020 | Routine Markers/Panels | RIT | CARDIAC / Myocardial Infaraction panel - CPK-MB, Troponin I, Tropni | SERUM (3 mL | Daily | 24 hrs |
543 | BGGNP019 | Routine Markers/Panels | RIT | COAGULATION PROFILE - CBC, BT, CT, APTT, | SERUM (3 mL), Citrate Plasma (3 mL) | Daily | 24 hrs |
544 | BGGNP018 | Routine Markers/Panels | LBC, real time PCR | CERVICAL SCREEN PAP | cervical sample | Daily | 2 days |
545 | BGGNP017 | Routine Markers/Panels | RIT | BOH PANEL – Cardiolipin ANTIbody IgA, IgG, IgM & LUPUS ANTI-Coagulant | SERUM (3 mL), Citrate Plasma (3 mL) | Daily | 24 hrs |
546 | BGGNP016 | Routine Markers/Panels | IFA | AUTOIMMUNE HEPATITIS PANEL – ANA, AMA, ASMA, Anti LKM Ab | SERUM (3 mL) | Daily | 2 Days |
547 | BGGNP015 | Routine Markers/Panels | RIT | ARTHRITIS PANEL CBC, CRP, | WB- EDTA & SERUM (3 mL) | Daily | 24 hrs |
548 | BGGNP014 | Routine Markers/Panels | EIA | ANTI THYROID ANTIBODY PANEL ANTI Thyroglobulin ANTIbody (ATG | SERUM (3 mL) | Daily | 24 hrs |
549 | BGGNP013 | Routine Markers/Panels | RIT | ANTENATAL PANEL - CBP, Blood Group, CUE, Viral Screening - HIV, HCV & HBV, VDRL, RBS, TSH, Sr Creatinine | WB – EDTA (2mL), Plasma – Flouride (2mL) , Serum (2mL), Urine (5mL | Daily | 24 hrs |
550 | BGGNP012 | Routine Markers/Panels | CLIA | ANDROLOGY PANEL - FSH, LH, TESTOSTERONE Total & Free | SERUM (3 mL) | Daily | 24 hrs |
551 | BGGNP011 | Routine Markers/Panels | IMMUNOBLOT | ANA BLOT PROFILE - 17 Autoimmune Markers | SERUM (3 mL) | Daily | 24 hrs |
552 | BGGNP010 | Routine Markers/Panels | RIT | ANAEMIA PANEL (IRON STUDIES) – CBC, FERRITIN, CRP, SERUM IRON , TIBC, F | WB- EDTA & SERUM (3 mL) | Daily | 24 hrs |
553 | BGGNP009 | Routine Markers/Panels | CLIA | AMENORRHOEA PROFILE - (Female infertility screening) (Estradiol, FSH, LH, Prolactin, Progesterone, TSH) | SERUM (3 mL) | Daily | 24 hrs |
554 | BGGNP008 | Routine Markers/Panels | IMMUNO CAP | ALLERGY SCREEN – GRASSES | SERUM (3 mL) | Daily | 2 Days |
555 | BGGNP007 | Routine Markers/Panels | IMMUNO CAP | ALLERGY SCREEN – WEEDS | SERUM (3 mL) | Daily | 2 Days |
556 | BGGNP006 | Routine Markers/Panels | IMMUNO CAP | ALLERGY SCREEN – FOOD (NON VEG) | SERUM (3 mL) | Daily | 2 Days |
557 | BGGNP005 | Routine Markers/Panels | IMMUNO CAP | ALLERGY SCREEN – FOOD (VEG) | SERUM (3 mL) | Daily | 2 Days |
558 | BGGNP004 | Routine Markers/Panels | IMMUNO CAP | ALLERGY SCREEN – ASTHMA & RHINITIS | SERUM (3 mL) | Daily | 2 Days |
559 | BGGNP003 | Routine Markers/Panels | IMMUNO CAP | ALLERGY COMPREHENSIVE PROFILE - Include 6 Allergy panels | SERUM (3 mL) | Daily | 2 Days |
560 | BGGNP002 | Routine Markers/Panels | CMIA, NEPHLOMETRY | ACUTE KIDNEY INJURY PANEL - Cystatin C, NGAL, Creatinine, Fractional excretion of Sodium, | SERUM (3 mL) | Daily | 2 Days |
561 | BGGNP001 | Routine Markers/Panels | FLOW, PCR | ABORTION PANEL CD3, CD19, CD16, CD56, TNF Alpha, HLADR & | WB- EDTA (3 mL) | Daily | 5 Days |
562 | BGGN356 | Routine Markers/Panels | spectrometry | Zinc | Serum (2 mL) / Urine ( 3mL) | Daily | 24 hrs |
563 | BGGN355 | Routine Markers/Panels | Agglutination | Weil Felix Test | Serum (2 mL) | Daily | 24 hrs |
564 | BGGN354 | Routine Markers/Panels | Chemical | VMA (Vanillyl Mandelic Acid) SPOT | Urine - Random (5mL) | Daily | 24 hrs |
565 | BGGN353 | Routine Markers/Panels | Chromatography | VMA (Vanillyl Mandelic Acid) | Urine(5 mL) & 24hrsUrine | Daily | 24 hrs |
566 | BGGN352 | Routine Markers/Panels | ELISA | Vitamin E (Tocopherol) | serum (2 mL) | Daily | 24 hrs |
567 | BGGN351 | Routine Markers/Panels | ELISA | Vitamin D3 (1,25 - Di Hydroxy Cholecalciferol) | Serum (2 mL) | Daily | 24 hrs |
568 | BGGN350 | Routine Markers/Panels | CLIA | Vitamin D (25-Hydroxy) Total | Serum (2 mL) | Daily | 24 hrs |
569 | BGGN349 | Routine Markers/Panels | CLIA | Vitamin B12 | Serum (2 mL) | Daily | 24 hrs |
570 | BGGN348 | Routine Markers/Panels | HPLC | Vitamin A | Serum (2 mL) | Daily | 24 hrs |
571 | BGGN347 | Routine Markers/Panels | ELISA | Varicella Zoster IgM | Serum (2 mL) | Daily | 24 hrs |
572 | BGGN346 | Routine Markers/Panels | ELISA | Varicella Zoster IgG | Serum (2 mL) | Daily | 24 hrs |
573 | BGGN345 | Routine Markers/Panels | CLIA / EIA | VALPROIC ACID (Sodium Valproate) | Serum (2 mL) | Daily | 24 hrs |
574 | BGGN344 | Routine Markers/Panels | Spectrometry | Uric Acid | Serum (2 mL) / Urine (10mL) | Daily | 24 hrs |
575 | BGGN343 | Routine Markers/Panels | Spectrometry | Urea | Serum (2 mL) / Urine (10 mL) | Daily | 24 hrs |
576 | BGGN342 | Routine Markers/Panels | IFA | U1-RNP Antibodies | Serum (2 mL) | Daily | 24hrs |
577 | BGGN341 | Routine Markers/Panels | culture | Urine Culture & Sensitivity | Urine(10mL) | Daily | 3 days |
578 | BGGN340 | Routine Markers/Panels | Immunochromatography | Typhi Dot - S typhi IgM | Serum (2 mL) | Daily | 24 hrs |
579 | BGGN339 | Routine Markers/Panels | ELISA | Tumor Necrosis Factor Alpha (TNF - a) | Serum (2 mL) | Daily | 24 hrs |
580 | BGGN338 | Routine Markers/Panels | Chromatography | Troponin – T | Serum | Daily | 24 hrs |
581 | BGGN337 | Routine Markers/Panels | Chromatography | Troponin – I | Serum | Daily | 24 hrs |
582 | BGGN336 | Routine Markers/Panels | CLIA | Triiodothyronine – Total (TT3) | Serum (2 mL) | Daily | 24 hrs |
583 | BGGN335 | Routine Markers/Panels | CLIA | Triiodothyronine – Free (FT3) | Serum (2 mL) | Daily | 24 hrs |
584 | BGGN334 | Routine Markers/Panels | Chromatography | TreponemaPalladium Hemagglutination (TPHA) | Serum (2 mL) | Daily | 24 hrs |
585 | BGGN333 | Routine Markers/Panels | Turbidometry | Transferrin | Serum (2 mL) | Daily | 24 hrs |
586 | BGGN332 | Routine Markers/Panels | EIA | Transforming Growth Factor Beta 1 (TGF b1) | Serum (2 mL) | Daily | 24 hrs |
587 | BGGN331 | Routine Markers/Panels | ELISA/CLIA | Toxoplasma gondii IgM | Serum (2 mL) | Daily | 24 hrs |
588 | BGGN330 | Routine Markers/Panels | ELISA/CLIA | Toxoplasma gondii IgG | Serum (2 mL) | Daily | 24 hrs |
589 | BGGN329 | Routine Markers/Panels | ELISA | Tissue Transglutaminase ANTIbodyIgM | Serum (2 mL) | Daily | 24 hrs |
590 | BGGN328 | Routine Markers/Panels | ELISA | Tissue Transglutaminase ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
591 | BGGN327 | Routine Markers/Panels | ELISA | Tissue Transglutaminase ANTIbody IgA | Serum (2 mL) | Daily | 24 hrs |
592 | BGGN326 | Routine Markers/Panels | CLIA | Thyroxin Binding Globulin (TBG) | Serum (2 mL) | Daily | 24 hrs |
593 | BGGN325 | Routine Markers/Panels | CLIA | Thyroxine – Total (TT4) | Serum (2 mL) | Daily | 24 hrs |
594 | BGGN324 | Routine Markers/Panels | CLIA | Thyroxine – Free (FT4) | Serum (2 mL) | Daily | 24 hrs |
595 | BGGN323 | Routine Markers/Panels | CLIA | Thyroid Stimulating Hormone (TSH) | Serum (2 mL) | Daily | 24 hrs |
596 | BGGN322 | Routine Markers/Panels | CLIA | Thyroglobulin | Serum (2 mL) | Daily | 24 hrs |
597 | BGGN321 | Routine Markers/Panels | Clotting | Thrombin Time | Citrated Plasma (2 mL) | Daily | 24 hrs |
598 | BGGN320 | Routine Markers/Panels | ELISA | Tetanus IgG | Serum (2 mL) | Daily | 72 hrs |
599 | BGGN319 | Routine Markers/Panels | CLIA | Testosterone -Total | Serum (2 mL) | Daily | 24 hrs |
600 | BGGN318 | Routine Markers/Panels | ELISA | Testosterone - Free | Serum (2 mL) | Daily | 24 hrs |
601 | BGGN317 | Routine Markers/Panels | ELISA | TB Gold QuANTIferon | Mitogen/Nil/ANTIgen/lithium hep | Daily | 48 hrs |
602 | BGGN316 | Routine Markers/Panels | ELISA | Tacrolimus Assay for kidney transplants | WB-EDTA /Heparin (4 mL) | Daily | 24 hrs |
603 | BGGN315 | Routine Markers/Panels | EIA | Syphilis Antibodies (VDRL) | Serum (2 mL) | Daily | 24 hrs |
604 | BGGN314 | Routine Markers/Panels | Guaiac-based FOBT | Stool Occult Blood | Stool 3 gr | Daily | 24 hrs |
605 | BGGN313 | Routine Markers/Panels | ELISA | Soluble Liver Antigen (SLA) | Serum (2 mL) | Daily | 24 hrs |
606 | BGGN312 | Routine Markers/Panels | Spectrometry | Sodium | Serum (2 mL) / 24 hrs Urine (volume) | Daily | 24 hrs |
607 | BGGN311 | Routine Markers/Panels | ELISA | Sm/RNP Antibody | Serum (2 mL) | Daily | 24 hrs |
608 | BGGN310 | Routine Markers/Panels | LC – MS/MS | SIROLIMUS LEVELS | WB-EDTA (3 mL) | Daily | 24 hrs |
609 | BGGN309 | Routine Markers/Panels | ELISA | Sex hormone binding globulin (SHBG) | Serum (2 mL) | Daily | 24 hrs |
610 | BGGN308 | Routine Markers/Panels | ELISA | Scrub typhus (Rickettsia) - IgM | Serum (2 mL) | Daily | 24 hrs |
611 | BGGN307 | Routine Markers/Panels | ELISA | SCL-70 (Scleroderma) Antibody | Serum (2 mL) | Daily | 24 hrs |
612 | BGGN306 | Routine Markers/Panels | ELISA | Salmonella typhi IgM | Serum (2 mL) | Daily | 24 hrs |
613 | BGGN305 | Routine Markers/Panels | ELISA | Rubella Virus IgM | Serum (2 mL) | Daily | 24 hrs |
614 | BGGN304 | Routine Markers/Panels | ELISA | Rubella Virus IgG | Serum (2 mL) | Daily | 24 hrs |
615 | BGGN303 | Routine Markers/Panels | ELISA | Rheumatic Factor (RA) | Serum (2 mL) | Daily | 24 hrs |
616 | BGGN302 | Routine Markers/Panels | ELISA | Rheumatic Factor IgA | Serum (2 mL) | Daily | 24 hrs |
617 | BGGN301 | Routine Markers/Panels | RIA | Renin Activity | WB-EDTA Plasma (3mL) | Daily | 24 hrs |
618 | BGGN300 | Routine Markers/Panels | CLIA | RBC Folate | WB-EDTA (3mL) | Daily | 24 hrs |
619 | BGGN299 | Routine Markers/Panels | Clotting | Prothrombin Time (PT) | Citrated Plasma (2 mL) | Daily | 24 hrs |
620 | BGGN298 | Routine Markers/Panels | Electrophoresis | URINE Protein Electrophoresis for M band | Urine (10 mL) & 24 hrs Urine Vol. | Daily | 24 hrs |
621 | BGGN297 | Routine Markers/Panels | Electrophoresis | Protein Electrophoresis (serum) for M band | Serum (2 mL) | Daily | 24 hrs |
622 | BGGN296 | Routine Markers/Panels | Spectrometry | Protein – Total | Serum, body fluids (2 mL) | Daily | 24 hrs |
623 | BGGN295 | Routine Markers/Panels | ELISA | Protein–S | Citrated Plasma (2 mL) | Daily | 24 hrs |
624 | BGGN294 | Routine Markers/Panels | ELISA | Protein – C | Citrated Plasma (2 mL) | Daily | 24 hrs |
625 | BGGN293 | Routine Markers/Panels | CLIA | Prostate Specific ANTIgen – PSA (Total) | Serum (2 mL) | Daily | 24 hrs |
626 | BGGN292 | Routine Markers/Panels | CLIA | Prostate Specific ANTIgen – PSA (Free) | Serum (2 mL) | Daily | 24 hrs |
627 | BGGN291 | Routine Markers/Panels | CLIA | Prolactin | Serum (2 mL) | Daily | 24 hrs |
628 | BGGN290 | Routine Markers/Panels | CLIA | Progesterone | Serum (2 mL) | Daily | 24 hrs |
629 | BGGN289 | Routine Markers/Panels | CLIA | Procalcitonin | Serum (2 mL) | Daily | 24 hrs |
630 | BGGN288 | Routine Markers/Panels | Spectrometry | Potassium | Serum (2 mL) / 24 hrs Urine (volume) | Daily | 24 hrs |
631 | BGGN287 | Routine Markers/Panels | Chromatography | Porphobilinogen (PBG) | Urine (10 mL) & 24 hrsUrine Vol. | Daily | 24 hrs |
632 | BGGN286 | Routine Markers/Panels | RIA | Plasma Renin Activity | Plama EDTA ( 3mL) | Daily | 48 hrs |
633 | BGGN285 | Routine Markers/Panels | Spectrometry | phosphorus | Serum (2 mL) / 24 hrs Urine (volume) | Daily | 24 hrs |
634 | BGGN284 | Routine Markers/Panels | CLIA | Phenytoin (Eptoin) | Serum (2 mL) | Daily | 24 hrs |
635 | BGGN282 | Routine Markers/Panels | CLIA | Phenobarbital (Phenobarbitone) | Serum (2 mL) | Daily | 24 hrs |
636 | BGGN281 | Routine Markers/Panels | ELISA | PHOSPHO LIPASE A2 RECEPTOR Ab (PLA2R Antibodies) | Serum (2 mL) | Daily | 1 WEEK |
637 | BGGN280 | Routine Markers/Panels | ELISA | Parietal Cell ANTIbody | Serum (2 mL) | Daily | 3 DAYS |
638 | BGGN279 | Routine Markers/Panels | CLIA | PAPP-A (Pregnancy Associated Plama Protein – A) | Serum (2 mL) | Daily | 24 hrs |
639 | BGGN278 | Routine Markers/Panels | Spectrophotometry | Oxalate | Urine Random / 24 hrs (5mL) | Daily | 48 hrs |
640 | BGGN277 | Routine Markers/Panels | ECLIA | Osteocalcin (BGP) | Serum (2 mL) | Daily | 48 hrs |
641 | BGGN276 | Routine Markers/Panels | Spectrometry | Osmotic Fragility Test | WB Na. Heparin (3mL) | Daily | 24 hrs |
642 | BGGN275 | Routine Markers/Panels | Spectrometry | Osmolality - Serum | Serum (2 mL) | Daily | 24 hrs |
643 | BGGN274 | Routine Markers/Panels | Spectrometry | Osmolality - Urine | Urine Random (5mL) | Daily | 24 hrs |
644 | BGGN273 | Routine Markers/Panels | LFIA | Opiates Screen ( Marijuana) | Urine (10 mL) | Daily | 24 hrs |
645 | BGGN272 | Routine Markers/Panels | Electrophoresis | Oligoclonal Bands | CSF ( 2ML) | Daily | 48 hrs |
646 | BGGN271 | Routine Markers/Panels | Microscopy | Nitro Blue Tetrazolium Assay (NBT) ( Granulomatous Test) | WB Na. Heparin (3mL) | Daily | 48 hrs |
647 | BGGN270 | Routine Markers/Panels | ECLIA | Myoglobin | Serum (2 mL) | Daily | 24 hrs |
648 | BGGN269 | Routine Markers/Panels | ELISA | Mycoplasma pneumonia IgM | Serum (2 mL) | Daily | 48 hrs |
649 | BGGN268 | Routine Markers/Panels | ELISA | Mycoplasma pneumonia IgG | Serum (2 mL) | Daily | 48 hrs |
650 | BGGN267 | Routine Markers/Panels | ELISA | Mumps Virus ANTIbody IgM | Serum (2 mL) | Daily | 24 hrs |
651 | BGGN266 | Routine Markers/Panels | ELISA | Mumps Virus ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
652 | BGGN265 | Routine Markers/Panels | Agglutination | Monotest ( INFECTIOUS MONO NUCLEOSIS) | Serum (2 mL) | Daily | 24 hrs |
653 | BGGN263 | Routine Markers/Panels | Turbidometry | Microalbumin | Urine - Random (5mL) | Daily | 24 hrs |
654 | BGGN262 | Routine Markers/Panels | Chromatography | Metanephrines | Urine (10 mL) & 24 hrs Urine | Daily | 48 hrs |
655 | BGGN261 | Routine Markers/Panels | ICPMS | Mercury | Urine (10 mL) | Daily | 24 hrs |
656 | BGGN260 | Routine Markers/Panels | ELISA | Measles (Rubeola) ANTIbody IgM | Serum (2 mL) | Daily | 24 hrs |
657 | BGGN259 | Routine Markers/Panels | ELISA | Measles (Rubeola) ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
658 | BGGN258 | Routine Markers/Panels | ICPMS | Manganese | WB EDTA (3mL) / Urine(10 mL) | Daily | 24 hrs |
659 | BGGN257 | Routine Markers/Panels | ELISA | Malaria Falciparum & Vivax ANTIgen (Parasite V&F) | Serum (2 mL) | Daily | 24 hrs |
660 | BGGN256 | Routine Markers/Panels | Xyldyl Blue | Magnesium | Serum (2 mL) / Urine (10 mL) | Daily | 24 hrs |
661 | BGGN255 | Routine Markers/Panels | UV/VIS Spectorscopy | METHEMOGLOBIN | WB EDTA (2 mL) | Daily | 2 DAYS |
662 | BGGN254 | Routine Markers/Panels | E M Clot Assay | Lupus ANTIcoagulant (LA) | Na CitratePlasma (3 mL) | Daily | 24 hrs |
663 | BGGN253 | Routine Markers/Panels | ELISA | Liver Kidney Microsomal (LKM) 1ANTIbody | Serum (2 mL) | Daily | 1 DAY |
664 | BGGN252 | Routine Markers/Panels | ISEDirect | Lithium (Li) | Serum (2 mL) | Daily | 24 hrs |
665 | BGGN251 | Routine Markers/Panels | Spectrometry | Lipoprotein A (Lp-a) | Serum (2 mL) | Daily | 24 hrs |
666 | BGGN250 | Routine Markers/Panels | ELISA | Lipo polysaccharides | Serum (2 mL) | Daily | 48hrs |
667 | BGGN249 | Routine Markers/Panels | Turbidometry | Lipase | Serum (2 mL) | Daily | 24 hrs |
668 | BGGN248 | Routine Markers/Panels | CLIA | Leuteinising Hormone (LH) | Serum (2 mL) | Daily | 24 hrs |
669 | BGGN247 | Routine Markers/Panels | Cytochemistry | Leucocyte Alkaline Phosphotase (LAP score) | Fresh blood smear | Daily | 24 hrs |
670 | BGGN246 | Routine Markers/Panels | microscopy | Leptospira Detection | WB EDTA (3mL) / Urine(25 mL) | Daily | 24 hrs |
671 | BGGN245 | Routine Markers/Panels | ELISA | Leptospira ANTIbody IgM | Serum (2 mL) | Daily | 24 hrs |
672 | BGGN244 | Routine Markers/Panels | ELISA | Leptospira ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
673 | BGGN243 | Routine Markers/Panels | ELISA | Leishmania (Kala Azar) ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
674 | BGGN242 | Routine Markers/Panels | AAS | Lead | WB EDTA(3mL) / Urine (10mL) | Daily | 24 hrs |
675 | BGGN241 | Routine Markers/Panels | Nephlometry | LAMBDA light chains, Serum | Serum (2 mL) | Daily | 24 hrs |
676 | BGGN240 | Routine Markers/Panels | Spectrometry | Lactate Dehydrogenase (LDH) | Serum, CSF, Pleural, Ascitic Fluid | Daily | 24 hrs |
677 | BGGN239 | Routine Markers/Panels | Spectrometry | Lactate | CSF, Plasma Fluoride(2 mL) | Daily | 24 hrs |
678 | BGGN238 | Routine Markers/Panels | chromatography | 17 – Ketosteriods | Urine (10mL) 24 hrs | Daily | 24 hrs |
679 | BGGN237 | Routine Markers/Panels | Biochemical | Kidney Stone Analysis | stone | Daily | 48 hrs |
680 | BGGN235 | Routine Markers/Panels | ELISA | Jo – 1 ANTIbody | Serum (2 mL) | Daily | 24 hrs |
681 | BGGN234 | Routine Markers/Panels | Spectrometry | Iron Binding Capacity Total (TIBC) | Serum (2 mL) | Daily | 24 hrs |
682 | BGGN233 | Routine Markers/Panels | Spectrometry | Iron, Serum | Serum (2 mL) | Daily | 24 hrs |
683 | BGGN232 | Routine Markers/Panels | Agglutination | Intrinsic Factor IgG ANTIbody | Serum (2 mL) | Daily | 3 DAYS |
684 | BGGN231 | Routine Markers/Panels | ELISA | Interleukin 6 (IL-6) | Serum (2 mL) | Daily | ELISA |
685 | BGGN230 | Routine Markers/Panels | CLIA | Intact Parathyroid Hormone (iPTH) | Serum (2 mL) | Daily | 24 hrs |
686 | BGGN229 | Routine Markers/Panels | CLIA | Insulin Like Growth Factor (IGFI) | Serum (2 mL) | Daily | 24 hrs |
687 | BGGN228 | Routine Markers/Panels | ELISA | Insulin ANTIbodies | Serum (2 mL) | Daily | 48 hrs |
688 | BGGN227 | Routine Markers/Panels | CMIA | Insulin (Fasting / PP / Random) | Serum (2 mL) | Daily | 24 hrs |
689 | BGGN226 | Routine Markers/Panels | ELISA | Inhibin–B | Serum (2 mL) | Daily | 24 hrs |
690 | BGGN225 | Routine Markers/Panels | ELISA | Inhibin–A (Pregnancy marker) | Serum (2 mL) | Daily | 24 hrs |
691 | BGGN224 | Routine Markers/Panels | EIA | Immunoglobulin IgE | Serum (2 mL) | Daily | 24 hrs |
692 | BGGN223 | Routine Markers/Panels | Turbidometry | Immunoglobulin IgM | Serum (2 mL) | Daily | 24 hrs |
693 | BGGN222 | Routine Markers/Panels | Turbidometry | Immunoglobulin IgG | Serum (2 mL) | Daily | 24 hrs |
694 | BGGN221 | Routine Markers/Panels | Turbidometry | Immunoglobulin IgA | Serum (2 mL) | Daily | 24 hrs |
695 | BGGN220 | Routine Markers/Panels | Electrophoresis | SERUM IMMUNFIXATION ELECTROPHORESIS IFE) | Serum (2 mL) | Daily | 2 DAYS |
696 | BGGN219 | Routine Markers/Panels | Chromatography | 5-Hydroxy Indole Acetic Acid (5-HIAA) | Urine(10 mL) & 24 hrs Volume | Daily | 24 hrs |
697 | BGGN218 | Routine Markers/Panels | CLIA | Human Growth Hormone (HGH) | Serum (2 mL) | Daily | 24 hrs |
698 | BGGN217 | Routine Markers/Panels | ELISA | HTLV 1 & 2 ANTIbodies | Serum (2 mL) | Daily | 24 hrs |
699 | BGGN216 | Routine Markers/Panels | CLIA | Homocysteine | Serum(2 mL) | Daily | 24 hrs |
700 | BGGN215 | Routine Markers/Panels | Western Blot | HIV 1 & 2 Western Blot Assay | Serum (2 mL) | Daily | 24 hrs |
701 | BGGN214 | Routine Markers/Panels | ELISA/CLIA | HIV 1 & 2 ANTIbody screening (include P24 Ag) | Serum (2 mL) | Daily | 24 hrs |
702 | BGGN213 | Routine Markers/Panels | ELISA | Histone Antibodies | Serum (2 mL) | Daily | 3 |
703 | BGGN212 | Routine Markers/Panels | ELISA | Herpes Simplex Virus 1 & 2 IgM | Serum (2 mL) | Daily | 24 hrs |
704 | BGGN211 | Routine Markers/Panels | ELISA | Herpes Simplex Virus 1 & 2 IgG | Serum (2 mL) | Daily | 24 hrs |
705 | BGGN210 | Routine Markers/Panels | ELISA | Hepatitis E virus ANTIbody IgM (ANTI HEV) | Serum (2 mL) | Daily | 24 hrs |
706 | BGGN209 | Routine Markers/Panels | ELISA | Hepatitis E virus ANTIbody IgG (ANTI HEV) | Serum (2 mL) | Daily | 24 hrs |
707 | BGGN208 | Routine Markers/Panels | ELISA | Hepatitis Delta Antibody IgM (Anti HDV) | Serum (2 mL) | Daily | 24 hrs |
708 | BGGN207 | Routine Markers/Panels | ELISA/CLIA | Hepatitis C Virus Antibody (Anti HCV) | Serum (2 mL) | Daily | 24 hrs |
709 | BGGN206 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B surface Antibody Total (ANTI HBs) | Serum (2 mL) | Daily | 24 hrs |
710 | BGGN205 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus Surface Antigen (HBs Ag) quantification | Serum (2 mL) | Daily | 24 hrs |
711 | BGGN204 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus Surface Antigen(HBsAg) | Serum (2 mL) | Daily | 24 hrs |
712 | BGGN203 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus envelope Antigen (HBeAg) | Serum (2 mL) | Daily | 24 hrs |
713 | BGGN202 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus envelope Antibody (Anti HBeAg) | Serum (2 mL) | Daily | 24 hrs |
714 | BGGN201 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus core ANTIbody Total (HBc Ab Total) | Serum (2 mL) | Daily | 24 hrs |
715 | BGGN200 | Routine Markers/Panels | ELISA/CLIA | Hepatitis B Virus core Antibody IgM (ANTI HBc IgM) | Serum (2 mL) | Daily | 24 hrs |
716 | BGGN199 | Routine Markers/Panels | ELISA/CLIA | Hepatitis A virus ANTIbody IgM (ANTI HAV) | Serum (2 mL) | Daily | 24 hrs |
717 | BGGN198 | Routine Markers/Panels | ELISA/CLIA | Hepatitis A virus ANTIbody IgG (ANTI HAV) | Serum (2 mL) | Daily | 24 hrs |
718 | BGGN197 | Routine Markers/Panels | HPLC | Hemoglobin Electrophoresis (Hb Electrophoresis) | WB-EDTA(3mL) | Daily | 24 hrs |
719 | BGGN196 | Routine Markers/Panels | ELISA | Helicobacter Pylori IgM | Serum (2 mL) | Daily | 24 hrs |
720 | BGGN195 | Routine Markers/Panels | ELISA | Helicobacter Pylori IgG | Serum (2 mL) | Daily | 24 hrs |
721 | BGGN194 | Routine Markers/Panels | TURBIDOMETRY | HAPTAGLOBULIN | Serum (2 mL) | Daily | 24 hrs |
722 | BGGN193 | Routine Markers/Panels | EIA | Glycoprotein IgM | Serum (2 mL) | Daily | 24 hrs |
723 | BGGN192 | Routine Markers/Panels | HPLC | Glycosylated Hemoglobin (G Hb/ HBA1c) | WB-EDTA(3mL) | Daily | 24 hrs |
724 | BGGN191 | Routine Markers/Panels | DELFIA | Glucose 6 Phosphate Dehydrogenase (G6PD) screen | Heel prick blood on filter paper | Daily | 24 hrs |
725 | BGGN190 | Routine Markers/Panels | Spectrophotometry | Glucose FBS/ PPBS / RBS | Plasma in Flouride tube (2 mL) | Daily | 24 hrs |
726 | BGGN189 | Routine Markers/Panels | Spectrophotometry | Glomerular Filtration Rate (GFR) | Serum (2 mL) | Daily | 2 days |
727 | BGGN188 | Routine Markers/Panels | ELISA | Glomerular Basement Membrane Ab IgG(ANTI GBM) | Serum (2 mL) | Daily | 2 days |
728 | BGGN187 | Routine Markers/Panels | ELISA | Gliadin ANTIbody IgM | Serum (2 mL) | Daily | 24 hrs |
729 | BGGN186 | Routine Markers/Panels | ELISA | Gliadin ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
730 | BGGN185 | Routine Markers/Panels | Microscopy | Giemsa Stain | Body fluids, biopsy, unstained smears | Daily | 24 hrs |
731 | BGGN184 | Routine Markers/Panels | CLIA | Gastrin, Serum | Serum (2 mL) | Daily | 24 hrs |
732 | BGGN183 | Routine Markers/Panels | Spectrophotometry | Gamma Glutamyl Transpeptidase (GGTP) | Serum (2 mL) | Daily | 24 hrs |
733 | BGGN182 | Routine Markers/Panels | ELISA | Galactomannan (Aspergillus Antigen), | Bronchoalveolar Lavage(BAL) | DAILY | 3 DAYS |
734 | BGGN181 | Routine Markers/Panels | CLIA | Follicle Stimulating Hormone (FSH) | Serum (2 mL) | Daily | 24 hrs |
735 | BGGN180 | Routine Markers/Panels | CLIA | Folate Serum (Folic Acid) | Serum (2 mL) | Daily | 24 hrs |
736 | BGGN179 | Routine Markers/Panels | IFA | Fluorescence Treponemal ANTIbodies (FTA)–ABS | Serum (2 mL) | Daily | 2 days |
737 | BGGN178 | Routine Markers/Panels | Immunoassay | Filaria / Microfilaria Antigen | Serum (2 mL) | Daily | 24 hrs |
738 | BGGN177 | Routine Markers/Panels | latex Agglutination | Fibrinogen Degradation product (PDP) | Plasma Citrated(2 mL) | Daily | 24 hrs |
739 | BGGN176 | Routine Markers/Panels | Clotting | Fibrinogen | Plasma Citrated(2 mL) | Daily | 24 hrs |
740 | BGGN175 | Routine Markers/Panels | CLIA | Ferritin | Serum (2 mL) | Daily | 24 hrs |
741 | BGGN174 | Routine Markers/Panels | ELISA | Fecal Calprotectin | Stool (2 gr) | Daily | 3 days |
742 | BGGN173 | Routine Markers/Panels | E M Clot detection | Factor – XII FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
743 | BGGN172 | Routine Markers/Panels | E M Clot detection | Factor – XI FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
744 | BGGN171 | Routine Markers/Panels | E M Clot detection | Factor – X FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
745 | BGGN170 | Routine Markers/Panels | E M Clot detection | Factor –IX FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
746 | BGGN169 | Routine Markers/Panels | E M Clot detection | Factor –VIII FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
747 | BGGN168 | Routine Markers/Panels | E M Clot detection | Factor –VII FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
748 | BGGN167 | Routine Markers/Panels | E M Clot detection | Factor-V FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
749 | BGGN166 | Routine Markers/Panels | E M Clot detection | Factor- II FUNCTIONAL | Citrated Plasma (2 mL) O/N Fasting | Daily | 3 days |
750 | BGGN165 | Routine Markers/Panels | Line Immunoassay | Extractable Nuclear ANTIgen (ENA) | Serum (2 mL) | Daily | 24 hrs |
751 | BGGN164 | Routine Markers/Panels | LC – MS/MS | EVEROLIMUS LEVELS | WB EDTA (2 mL) | Daily | 24 hrs |
752 | BGGN163 | Routine Markers/Panels | CLIA | Estriol, Unconjugated (E3) Free | Serum (2 mL) | Daily | 24 hrs |
753 | BGGN162 | Routine Markers/Panels | CLIA | Estradiol (E2) Titre | Serum (2 mL) | Daily | 24 hrs |
754 | BGGN161 | Routine Markers/Panels | CLIA | Estradiol (E2) | Serum (2 mL) | Daily | 24 hrs |
755 | BGGN160 | Routine Markers/Panels | CLIA | Erythropoietin (EPO) | Serum (2 mL) | Daily | 24 hrs |
756 | BGGN159 | Routine Markers/Panels | HEMATOLOGY | Erythrocyte Sedimentation Rate (ESR) | SODIUM CITRATE, WB EDTA | Daily | 24 hrs |
757 | BGGN158 | Routine Markers/Panels | ELISA | Epstein Barr Virus VCA IgG or IgM | Serum (2 mL) | Daily | 24 hrs |
758 | BGGN157 | Routine Markers/Panels | ELISA | Entamoeba histolytica ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
759 | BGGN156 | Routine Markers/Panels | EIA | FECAL ELASTSE | Stool 2 gr | Daily | 24 hrs |
760 | BGGN155 | Routine Markers/Panels | EIA | DIPTHERIA IgG ( Corynebacterium) | Serum (2 mL) | DAILY | 3 DAYS |
761 | BGGN154 | Routine Markers/Panels | ELISA | Endomysial ANTIbody IgA or IgG or IgM Each | Serum (2 mL) | Daily | 48 hrs |
762 | BGGN153 | Routine Markers/Panels | ELISA | Echinococcus ANTIbody, IgG (Hydatid Serology) | Serum (2 mL) | Daily | 24 hrs |
763 | BGGN152 | Routine Markers/Panels | CLIA / ELISA | Dihydro Testosterone ( 5a DHT) | Serum (2 mL) | Daily | 24 hrs |
764 | BGGN151 | Routine Markers/Panels | CLIA / EIA | DIGOXIN | Serum (2 mL) | Daily | 24 hrs |
765 | BGGN150 | Routine Markers/Panels | ELISA | Dengue NS1 ANTIgen | Serum (2 mL) | Daily | 24 hrs |
766 | BGGN149 | Routine Markers/Panels | ELISA | Dengue serology NS1 IgM & IgG | Serum (2 mL) | DAILY | 24 hrs |
767 | BGGN148 | Routine Markers/Panels | ELISA | Dengue ANTIbody IgM & IgG | Serum (2 mL) | Daily | 24 hrs |
768 | BGGN147 | Routine Markers/Panels | CLIA | Dehydro Epiandro sterone Sulphate (DHEAS) | Serum (2 mL) | Daily | 24 hrs |
769 | BGGN146 | Routine Markers/Panels | ELISA | Dehydro Epiandro sterone (DHEA) | Serum (2 mL) | Daily | 24 hrs |
770 | BGGN145 | Routine Markers/Panels | CLIA | D - DIMER | Plasma Na Citrated(2 mL) | Daily | 24 hrs |
771 | BGGN144 | Routine Markers/Panels | ELISA | Cytomegalo Virus (CMV) AVIDITY | Serum,CSF(2 mL) | Daily | 24 hrs |
772 | BGGN143 | Routine Markers/Panels | ELISA / CLIA | Cytomegalovirus IgG or IgM Each | Serum,CSF(2 mL) | Daily | 24 hrs |
773 | BGGN142 | Routine Markers/Panels | LBC | Cytology – PAP Smear from LBC | Endocervical smear in spl. liquid | Daily | 24 hrs |
774 | BGGN141 | Routine Markers/Panels | DELFIA | Cystic Fibrosis | Heel prick blood on filter paper | Daily | 2 days |
775 | BGGN140 | Routine Markers/Panels | Nephlometry | Cystatin – C | Serum (2 mL) | Daily | 24 hrs |
776 | BGGN139 | Routine Markers/Panels | LC – MS/MS | Cyclosporine | WB EDTA (2 mL) | Daily | 24 hrs |
777 | BGGN138 | Routine Markers/Panels | Culture | Culture and Sensitivity – AFB 10 DRUGS | AFB | Daily | 2 – 5 days |
778 | BGGN137 | Routine Markers/Panels | Culture | Culture and Sensitivity – AFB 5 DRUGS | AFB | Daily | 2 – 5 days |
779 | BGGN136 | Routine Markers/Panels | Automated Culture | Culture & Sensitivity - Anaerobic | Blood, Pus, Urine, Body fluids | Daily | 2 – 5 days |
780 | BGGN135 | Routine Markers/Panels | Automated Culture | Culture and Sensitivity - aerobic | Blood, Pus, Urine, Body fluids, Stool | Daily | 2 – 5 days |
781 | BGGN134 | Routine Markers/Panels | Agglutination | Cryptococcus Antigen | Serum (2 mL)/ CSF(2 mL) | Daily | 24 hrs |
782 | BGGN133 | Routine Markers/Panels | CLIA | Creatine Phospho Kinase NAC (CPK NAC) | Serum (2 mL) | Daily | 24 hrs |
783 | BGGN132 | Routine Markers/Panels | CLIA | Creatine Phospho Kinase MB (CPK MB) | Serum (2 mL) | Daily | 24 hrs |
784 | BGGN131 | Routine Markers/Panels | CLIA / EIA | Creatine Phospho Kinase (CK or CPK) | Serum (2 mL) | Daily | 24 hrs |
785 | BGGN130 | Routine Markers/Panels | Spectrometry | Creatinine | Serum (2 mL) / Urine (10mL) | Daily | 24 hrs |
786 | BGGN129 | Routine Markers/Panels | Nephlometry | CRP - High Sensitive (HS CRP) | Serum (2 mL) | Daily | 24 hrs |
787 | BGGN128 | Routine Markers/Panels | BIOCHEMISRY | C-REACTIVE PROTEIN (CRP) | Serum (2 mL) | Daily | 24 hrs |
788 | BGGN127 | Routine Markers/Panels | CLIA | C – PEPTIDE, fasting / post prandial | Serum (2 mL) | Daily | 24 hrs |
789 | BGGN126 | Routine Markers/Panels | CLIA | Cortisol Urine Total | 24 hrs Urine | Daily | 24 hrs |
790 | BGGN125 | Routine Markers/Panels | CLIA | Cortisol Serum (7 to9 AM) | Serum (2 mL) | Daily | 24 hrs |
791 | BGGN124 | Routine Markers/Panels | CLIA | Cortisol Serum (3 to5 PM) | Serum (2 mL) | Daily | 24 hrs |
792 | BGGN123 | Routine Markers/Panels | CLIA / EIA | Copper | Serum (2 mL) / Urine (10mL) | Daily | 24 hrs |
793 | BGGN122 | Routine Markers/Panels | Gel microtyping | Coombs (indirect) | Serum (2 mL) | Daily | 24 hrs |
794 | BGGN121 | Routine Markers/Panels | Gel microtyping | Coombs (direct) | WB EDTA (2 mL) | Daily | 24 hrs |
795 | BGGN120 | Routine Markers/Panels | Biochemistry | Complete Urine Examination (CUE) | Urine (10 mL) | Daily | 24 hrs |
796 | BGGN119 | Routine Markers/Panels | Cell counter | Complete Blood Count (CBC) Hemogram | WB in EDTA/HEPARIN (2 mL) | Daily | 8 hrs |
797 | BGGN118 | Routine Markers/Panels | Turbidometry | Complement 4 (C4) | Serum (2 mL) | Daily | 24 hrs |
798 | BGGN117 | Routine Markers/Panels | Turbidometry | Complement 3 (C3) | Serum (2 mL) | Daily | 24 hrs |
799 | BGGN116 | Routine Markers/Panels | DELFIA | Cocaine Screen | Urine (10 mL) | Daily | 24 hrs |
800 | BGGN115 | Routine Markers/Panels | Spectrometry | Citrate | Urine (10mL) | Daily | 24 hrs |
801 | BGGN114 | Routine Markers/Panels | ELISA | Chromogranin A | Serum (2 mL) | Daily | 24 hrs |
802 | BGGN113 | Routine Markers/Panels | ICPMS | Chromium | WB EDTA(3mL) / Urine (10mL) | Daily | 2 DAYS |
803 | BGGN112 | Routine Markers/Panels | Spectrometry | Cholinesterase | Serum (2 mL) | Daily | 24 hrs |
804 | BGGN111 | Routine Markers/Panels | Spectrometry | Chloride | Serum (2 mL) | Daily | 24 hrs |
805 | BGGN110 | Routine Markers/Panels | ELISA | Chlamydia trachomatis IgG | Serum (2 mL) | Daily | 24 hrs |
806 | BGGN109 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
807 | BGGN108 | Routine Markers/Panels | ELISA | Chikungunya ANTIbody IgG or IgM Each | Serum (2 mL) | Daily | 24 hrs |
808 | BGGN107 | Routine Markers/Panels | Nephlometry | Ceruloplasmin | Serum (2 mL) | Daily | 24 hrs |
809 | BGGN106 | Routine Markers/Panels | EIA / BLOT | Centromere ANTIbody IgG | Serum (2 mL) | Daily | 3 DAYS |
810 | BGGN105 | Routine Markers/Panels | Chromatography | Catecholamines | Urine(10 mL) 24 hrs | Daily | 3 DAYS |
811 | BGGN104 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
812 | BGGN103 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
813 | BGGN102 | Routine Markers/Panels | ELISA | Cardiolipin IgG & IgM & IgA Antibody Each | Serum (2 mL) | Daily | 24 hrs |
814 | BGGN101 | Routine Markers/Panels | CLIA / EIA | Carcino Embryonic ANTIgen (CEA) | Serum (2 mL) | Daily | 24 hrs |
815 | BGGN100 | Routine Markers/Panels | CLIA | Carbamazepine (Tegretol) | Serum (2 mL) | Daily | 24 hrs |
816 | BGGN099 | Routine Markers/Panels | LFIA | Cannabinoids Screen ( Marijuana) | Urine (10 mL) | Daily | 24 hrs |
817 | BGGN098 | Routine Markers/Panels | CLIA | Calcitonin | Serum (2 mL) | Daily | 24 hrs |
818 | BGGN097 | Routine Markers/Panels | Spectrometry | Calcium / Creatinine ratio | Urine (10 mL) | Daily | 24 hrs |
819 | BGGN096 | Routine Markers/Panels | Spectrometry | Calcium , Ionized | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
820 | BGGN095 | Routine Markers/Panels | Spectrometry | Calcium | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
821 | BGGN094 | Routine Markers/Panels | ICPMS | Cadmium | WB EDTA(3mL) / Urine (10mL) 24hrs | Daily | 24 hrs |
822 | BGGN093 | Routine Markers/Panels | CLIA | CYFRA 21-1(LUNG CANCER MARKER) | Serum (2 mL) | Daily | 24 hrs |
823 | BGGN092 | Routine Markers/Panels | CLIA | CA72.4 Gastric Cancer Marker | Serum (2 mL) | Daily | 4 DAYS |
824 | BGGN091 | Routine Markers/Panels | CLIA | CA19.9 Pancreatic Cancer Marker | Serum (2 mL) | Daily | 24 hrs |
825 | BGGN090 | Routine Markers/Panels | CLIA | CA15.3 Breast Cancer marker | Serum (2 mL) | Daily | 2 DAYS |
826 | BGGN089 | Routine Markers/Panels | CLIA | CA- 125 Ovarian Cancer marker | Serum (2 mL) | Daily | 24 hrs |
827 | BGGN088 | Routine Markers/Panels | XXX | XXXX | XXX | XXX | XXX |
828 | BGGN087 | Routine Markers/Panels | ELISA | Brucella IgG or IgM | Serum (2 mL) | Daily | 24 hrs |
829 | BGGN086 | Routine Markers/Panels | Agglutination | Brucella Agglutination test | Serum (2 mL) | Daily | 24 hrs |
830 | BGGN085 | Routine Markers/Panels | ELISA | Bone Morphogenic Factor (BMP – 7) | Serum (2 mL) | Daily | 24 hrs |
831 | BGGN084 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
832 | BGGN083 | Routine Markers/Panels | BACTEC | Blood Culture ( Anaerobic) | CULTURE BOTTLE | Daily | 5 days |
833 | BGGN082 | Routine Markers/Panels | BACTEC | Blood Culture ( Aerobic) | CULTURE BOTTLE | Daily | 5 days |
834 | BGGN081 | Routine Markers/Panels | Agglutination | Blood Grouping (ABO) | WB EDTA(2mL) | Daily | 24 hrs |
835 | BGGN080 | Routine Markers/Panels | Spectrometry | Bilirubin total / direct / indirect | Serum (2 mL), | Daily | 24 hrs |
836 | BGGN079 | Routine Markers/Panels | Spectrometry | Bicarbonate | Serum (2 mL) | Daily | 24 hrs |
837 | BGGN078 | Routine Markers/Panels | Chromatography | Benzodiazepines | Urine (10 mL) | Daily | 24 hrs |
838 | BGGN077 | Routine Markers/Panels | CLIA | b-Human Chorionic Gonodotropin Hormone (Free) | Serum(2 mL) | Daily | 24 hrs |
839 | BGGN076 | Routine Markers/Panels | CLIA | b-Human Chorionic Gonodotropin Hormone Titre | Serum (2 mL) | Daily | 24 hrs |
840 | BGGN075 | Routine Markers/Panels | CLIA | b-Human Chorionic Gonodotropin Hormone(b-HCG) | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
841 | BGGN074 | Routine Markers/Panels | CLIA | Beta 2 Microglobulin, Serum / Urine | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
842 | BGGN073 | Routine Markers/Panels | Biochemistry | BILE ACIDS | Serum (2 mL) | Daily | 4 Days |
843 | BGGN072 | Routine Markers/Panels | CLIA | Beta 2 Glycoprotein IgM & IgG EACH | Serum (2 mL) | Daily | 24 hrs |
844 | BGGN071 | Routine Markers/Panels | XXX | XXXXXX | XXX | XXX | XXX |
845 | BGGN070 | Routine Markers/Panels | Biochemical | Bence Jones Protein (BJ Protein) | Urine (10 mL) | Daily | 24 hrs |
846 | BGGN069 | Routine Markers/Panels | CLIA | B Type Natriuretic Peptide (BNP) | WB EDTA(3mL) | Daily | 24 hrs |
847 | BGGN068 | Routine Markers/Panels | XXX | XXXX | XXX | XXX | XXX |
848 | BGGN067 | Routine Markers/Panels | ELISA | Aspergillus ANTIbody IgG or IgM | Serum (2 mL) | Daily | 24 hrs |
849 | BGGN066 | Routine Markers/Panels | ICPMS | Arsenic blood / Urine | WB EDTA(3mL) / Urine (10 mL) | Daily | 24 hrs |
850 | BGGN065 | Routine Markers/Panels | Turbidometry | Apolipoprotein B (APOB) | Serum (2 mL) | Daily | 24 hrs |
851 | BGGN064 | Routine Markers/Panels | Turbidometry | Apolipoprotein A1 (APOA1) | Serum (2 mL) | Daily | 24 hrs |
852 | BGGN063 | Routine Markers/Panels | Turbidometry | ANTI Thrombin III (ANTIgenic) | Citrated Plasma (2 mL) | Daily | 24 hrs |
853 | BGGN062 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
854 | BGGN061 | Routine Markers/Panels | ELISA | ANTI Thyroglobulin ANTIbody (ATG) TITRE | Serum (2 mL) | Daily | 24 hrs |
855 | BGGN060 | Routine Markers/Panels | ELISA | ANTI Thyroglobulin ANTIbody (ATG) | Serum (2 mL) | Daily | 24 hrs |
856 | BGGN059 | Routine Markers/Panels | ELISA | ANTI Streptolysin ANTIbody (ASO) | Serum (2 mL) | Daily | 24 hrs |
857 | BGGN058 | Routine Markers/Panels | ELISA | ANTI Sperm ANTIbody (ASAB) | Serum (2 mL) | Daily | 24 hrs |
858 | BGGN057 | Routine Markers/Panels | IFA | ANTI Smooth Muscle ANTIbody (ASMA) Titre | Serum (2 mL) | Daily | 24 hrs |
859 | BGGN056 | Routine Markers/Panels | ELISA | ANTI Smooth Muscle ANTIbody (ASMA) | Serum (2 mL) | Daily | 3 DAYS |
860 | BGGN055 | Routine Markers/Panels | ELISA | ANTI Sm (SMITH) – ANTIbody IgG | Serum (2 mL) | Daily | 24 hrs |
861 | BGGN054 | Routine Markers/Panels | ELISA | CYTOMEGALO VIRUS IgG & IgM | SERUM 2mL | Daily | 24 HRS |
862 | BGGN053 | Routine Markers/Panels | ELISA | ANTI Saccharomyes Cereviaiae ANTIbody IgG or IgA | Serum (2 mL) | Daily | 24 hrs |
863 | BGGN052 | Routine Markers/Panels | XXX | XXXXX | XXX | XXX | XXX |
864 | BGGN051 | Routine Markers/Panels | ELISA | ANTI Phospholipid ANTIbody IgG & IgM | Serum (2 mL) | Daily | 24 hrs |
865 | BGGN050 | Routine Markers/Panels | ELISA | ANTI SSB (ANTI La) ANTIbody | Serum (2 mL) | Daily | 24 hrs |
866 | BGGN049 | Routine Markers/Panels | ELISA | ANTI SSA (ANTI Ro) ANTIbody | Serum (2 mL) | Daily | 24 hrs |
867 | BGGN048 | Routine Markers/Panels | IFA | ANTI Nuclear ANTIbody / Factor (ANA ANF) Titres | Serum (2 mL) | Daily | 24 hrs |
868 | BGGN047 | Routine Markers/Panels | ELISA | ANTI Nuclear ANTIbody / Factor (ANA ANF) | Serum (2 mL) | Daily | 24 hrs |
869 | BGGN046 | Routine Markers/Panels | ELISA | ANTI Mullerian Hormone (AMH) | Serum (2 mL) | Daily | 48 hrs |
870 | BGGN045 | Routine Markers/Panels | IFA | ANTI Mitochondrial ANTIbody Titre | Serum (2 mL) | Daily | 24 hrs |
871 | BGGN044 | Routine Markers/Panels | ELISA | ANTI Mitochondrial ANTIbody | Serum (2 mL) | Daily | 24 hrs |
872 | BGGN043 | Routine Markers/Panels | IFA | ANTI MIcrosomal / Thyroperoxidase ANTIbody - Titre | Serum (2 mL) | Daily | 24 hrs |
873 | BGGN042 | Routine Markers/Panels | CLIA | ANTI MIcrosomal / Thyroperoxidase ANTIbody | Serum (2 mL) | Daily | 24 hrs |
874 | BGGN041 | Routine Markers/Panels | ELISA | ANTI JO 1 ANTIbody | Serum (2 mL) | Daily | 24 hrs |
875 | BGGN040 | Routine Markers/Panels | IFA | ANTI dsDNA ANTIbody Titre | Serum (2 mL) | Daily | 24 hrs |
876 | BGGN039 | Routine Markers/Panels | ELISA | ANTI dsDNA ANTIbody | Serum (2 mL) | Daily | 24 hrs |
877 | BGGN038 | Routine Markers/Panels | Nephlometry | ANTI Dnase B ( ANTIdeoxyribonuclease B) | Serum (2 mL) | Daily | 2 days |
878 | BGGN037 | Routine Markers/Panels | ELISA | ANTI Cysticercosis (Taenia Solium) IgG ANTIbody | Serum (2 mL) | Daily | 2 days |
879 | BGGN036 | Routine Markers/Panels | ELISA | ANTI Cyclic Citrullinated Peptide ANTIbody (ANTI CCP) | Serum (2 mL) | Daily | 24 hrs |
880 | BGGN035 | Routine Markers/Panels | ELISA | ANCA Serine Proteinase 3 (C- ANCA) | Serum (2 mL) | Daily | 24 hrs |
881 | BGGN034 | Routine Markers/Panels | ELISA | ANCA Myeloperoxidase (P - ANCA) | Serum (2 mL) | Daily | 24 hrs |
882 | BGGN033 | Routine Markers/Panels | IFA | ANTI Neutrophilic Cytoplasmic ANTIbody (ANCA)Titre | Serum (2 mL) | Daily | 24 hrs |
883 | BGGN032 | Routine Markers/Panels | EIA | ANTI Neutrophilic Cytoplasmic ANTIbody (ANCA) | Serum (2 mL) | Daily | 24 hrs |
884 | BGGN031 | Routine Markers/Panels | Spectrometry | Angiotensin Converting Enzyme (ACE) | Serum (2 mL) | Daily | 24 hrs |
885 | BGGN030 | Routine Markers/Panels | CLIA | Androstenedione(A4) | Serum (2 mL) | Daily | 24 hrs |
886 | BGGN029 | Routine Markers/Panels | Spectrometry | Amylase | Serum / Urine (10 mL) | Daily | 24 hrs |
887 | BGGN028 | Routine Markers/Panels | Chromatography | Amphetamine | Urine (10 mL) | Daily | 24 hrs |
888 | BGGN027 | Routine Markers/Panels | Spectrometry | Ammonia | Plasma K2 EDTA (2 mL) | Daily | 24 hrs |
889 | BGGN026 | Routine Markers/Panels | Chromatography | Aminolevulinic Acid (ALA) | Urine(25 mL) 24 hrs Urine Volume | Daily | 24 hrs |
890 | BGGN025 | Routine Markers/Panels | ICP-AAS | Aluminium | Serum/ Plasma (2mL)/ Urine (10 mL) | Daily | 4 Days |
891 | BGGN023 | Routine Markers/Panels | BIOCHEMISTRY | Albumin Serum or CSF | Serum (2 mL) or CSF( 2 mL) | Daily | 24 hrs |
892 | BGGN022 | Routine Markers/Panels | ELISA | 17-Alpha Hydroxy Progesterone (17-OHP) | Serum (2 mL) | Daily | 24 hrs |
893 | BGGN021 | Routine Markers/Panels | Turbidometry | Alpha-1ANTItrypsin (AAT) | Serum (2 mL) | Daily | 24 hrs |
894 | BGGN020 | Routine Markers/Panels | CLIA | Alpha Feto Protein (AFP) TUMOR MARKER | Serum/Amniotic Fluid (2 mL) | Daily | 24 hrs |
895 | BGGN019 | Routine Markers/Panels | CLIA | Alpha Feto Protein (AFP) MATERNAL | Serum/Amniotic Fluid (2 mL) | Daily | 24 hrs |
896 | BGGN018 | Routine Markers/Panels | ELISA / Chromatography | ADENOVIRUS ANTIGEN | Serum (2 mL) | Daily | 24 hrs |
897 | BGGN017 | Routine Markers/Panels | Chemical | Alkaptonuria, QuANTItative | Urine (10 mL) | Daily | 24 hrs |
898 | BGGN016 | Routine Markers/Panels | Chemical | Alkaptonuria, Qualitative | Urine (10 mL) | Daily | 24 hrs |
899 | BGGN015 | Routine Markers/Panels | CLIA / ELISA | Aldosterone, Serum / Urine | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
900 | BGGN014 | Routine Markers/Panels | Spectrometry | Aldolase | Serum (2 mL) | Daily | 24 hrs |
901 | BGGN013 | Routine Markers/Panels | Spectrometry | Alcohol ( Ethanol Screen) | Serum (2 mL)/ Urine (10 mL) | Daily | 24 hrs |
902 | BGGN012 | Routine Markers/Panels | CLIA | Adreno Corticotrophic Hormone (ACTH) | Plasma EDTA(2mL) | Daily | 24 hrs |
903 | BGGN011 | Routine Markers/Panels | Spectrometry | Adenosine Deaminase (ADA) | Serum, CSF, body fluid, Pus(2 mL) | Daily | 24 hrs |
904 | BGGN010 | Routine Markers/Panels | Clotting Assay | Activated Partial Thromboplastin Time (APTT or PTT) | WB-Citrate (3mL) | Daily | 8 hrs |
905 | BGGN009 | Routine Markers/Panels | LPA | MTB LPA – 2nd line drugs Fluoroquinolones, Capreomycin, Viomycin, Amikacin, Kanamycin, & Ethambutol | Mycobacterium Culture | Daily | 2 DAYS |
906 | BGGN008 | Routine Markers/Panels | LPA | MTB LPA – 1st Line Drugs Rifampicin & Isoniazid | Mycobacterium Culture | Daily | 2 DAYS |
907 | BGGN007 | Routine Markers/Panels | BACTEC | Acid Fast Susceptibility – 5 drugs mycobacterium | Mycobacterium Culture | Daily | 3 weeks |
908 | BGGN006 | Routine Markers/Panels | BACTEC | Acid Fast Susceptibility – 10 drugs mycobacterium | Mycobacterium Culture | Daily | 3 weeks |
909 | BGGN005 | Routine Markers/Panels | Microscopy | AFB Staining | Blood, body fluids, sputum (2 mL) | Daily | 24 hrs |
910 | BGGN004 | Routine Markers/Panels | BACTEC | AFB culture | Blood, Body fluids, Urine | Daily | 3 DAYS |
911 | BGGN003 | Routine Markers/Panels | Spectrometry | Acid Phosphatase Total | Serum (2 mL) | Daily | 24 hrs |
912 | BGGN002 | Routine Markers/Panels | Spectrometry | Acid Phosphatase Prostatic (PAP) | Serum (2 mL) | Daily | 24 hrs |
913 | BGGN001 | Routine Markers/Panels | ELISA | Acetyl Choline Receptor ANTIbody | Serum (2 mL) | Daily | 2 DAYS |
914 | BGFL912 | Flowcytometry | FLOWCYTOMETRY | TBNK-T Cell B Cell & NK Cell Panel (CD 3-4-8-16/56-19-45) | Whole Blood / Bone Marrow in Na- Heparin and K2 - EDTA | Daily | 2 DAYS |
915 | BGFL911 | Flowcytometry | FLOWCYTOMETRY | Ankylosing Spondolitis - HLA B27 , B7 | Whole Blood in Na- Heparin / K2 - EDTA | Daily | 2 DAYS |
916 | BGFL910 | Flowcytometry | FLOWCYTOMETRY | HIV Flow Panel - Immuno deficiency (CD3/CD4/CD8 & CD45) | Whole Blood in Na- Heparin / K2 - EDTA | Daily | 1 DAY |
917 | BGFL909 | Flowcytometry | FLOWCYTOMETRY | PNH on RBCs (CD 55- 59 -GlyA-optional) | Whole Blood in K2 - EDTA | Daily | 2 DAYS |
918 | BGFL908 | Flowcytometry | FLOWCYTOMETRY | PNH on WBC (FLAER-24-15-14-64-45) | Whole Blood in K2 - EDTA | Daily | 2 DAYS |
919 | BGFL907 | Flowcytometry | FLOWCYTOMETRY | PNH COMPREHENSIVE (FLAER-CD24-15-14-64-45-59-GlyA-55optional) | Whole Blood in K2 - EDTA | Daily | 2 DAYS |
920 | BGFL906 | Flowcytometry | FLOWCYTOMETRY | STEM CELL Enumeration CD34 absolute Count and Viability | Whole Blood / Cord Blood / Bone Marrow in K2 - EDTA | Daily | 2 DAYS |
921 | BGFL905 | Flowcytometry | FLOWCYTOMETRY | CHRONIC LYMPHO PROLIFERATIVE DISORDER (CLPD) PANEL | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | Daily | 2 DAYS |
922 | BGFL903 | Flowcytometry | FLOWCYTOMETRY | CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) COMPREHENSIVE PANEL | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | Daily | 2 DAYS |
923 | BGFL901 | Flowcytometry | FLOWCYTOMETRY | ACUTE LEUKEMIA COMPREHENSIVE PANEL - ALL / AML . | Whole Blood / Bone Marrow in Na- Heparin & K2 - EDTA | Daily | 2 DAYS |
924 | BGPCR875 | Molecular | Real time PCR | HIV 2 RNA QUANTITATIVE (Viral Load) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
925 | BGPCR874 | Molecular | Real Time PCR | Y CHROMOSOME MICRODELETIONS (16 Mutations) | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
926 | BGPCR873 | Molecular | Real Time PCR | Varicella Zoster Virus (VZV) DNA QUALITATIVE | 2 – 3 mL blood or body fluids | Daily | 2 DAYS |
927 | BGPCR872 | Molecular | PCR + SEQUEN | UGT1A1 (GILBERT’S SYNDROME) | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
928 | BGPCR871 | Molecular | PCR + SEQUEN | TPMT (Thio Purine Methyl Transferase) genotyping | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
929 | BGPCR870 | Molecular | Real Time PCR | TOXOPLASMA – DNA Qualitative | 2 - 3 ml – serum, Body fluids | Daily | 2 DAYS |
930 | BGPCR869 | Molecular | Real Time PCR | THROMBOPHILIA PROFILE – Factor II (Prothrombin Gene Mutation, FACTOR V Leiden mutation, MTHFR Gene Mutation | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
931 | BGPCR868 | Molecular | PCR + MLPA | Spinal Muscular Atrophy (SMN1 & SMN2 ) Gene Analysis | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
932 | BGPCR867 | Molecular | PCR + SEQENCING | SCA (Spino Cerebellar Ataxia) Panel (1, 2, 3, 6, 7, 10 & 12, EXONS) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
933 | BGPCR866 | Molecular | Real Time PCR | Sickle Cell Anaemia Mutations | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
934 | BGPCR865 | Molecular | Real Time PCR | Rubella Virus – RNA Qualitative | 2 - 3 ml – SERUM/CSF/WB EDTA | Daily | 2 DAYS |
935 | BGPCR864 | Molecular | Real time PCR | PML/RARa (AML - M3) (APML) – Quantitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 2 DAYS |
936 | BGPCR863 | Molecular | Real time PCR | PML/RARa (AML - M3) (APML) – Qualitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 2 DAYS |
937 | BGPCR862 | Molecular | Real Time PCR | PARVO VIRUS B19 DNA – Qualitative | 2 - 3 ml – serum, Body fluids | Daily | 2 DAYS |
938 | BGPCR861 | Molecular | Sequencing | Non Invasive Prenatal Testing (NIPT) | 4 - 5 ml – Maternal Blood | Daily | 10 DAYS |
939 | BGPCR860 | Molecular | PCR | NPM1 ( Nucleophosmin -1) gene mutation Assay | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3 DAYS |
940 | BGPCR859 | Molecular | Real time PCR | MTB (M. Tuberculosis) Complex Qualitative | 2 - 3 ml Sputum, CSF, Body fluids | Daily | 2 DAYS |
941 | BGPCR858 | Molecular | PCR + SEQUEN | MPL – Myelo Proliferative Leukemia Assay | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
942 | BGPCR857 | Molecular | Real time PCR | MTHFR - Gene Mutation (Homocysteinemia) Assay | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
943 | BGPCR856 | Molecular | PCR + SEQUEN | KRAS (Colorectal Cancer Marker) MUTATIONS | Paraffin Tissue Block | Daily | 5 DAYS |
944 | BGPCR855 | Molecular | PCR + SEQUEN | JAK2 mutation panel (Exon 12 – 15) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
945 | BGPCR854 | Molecular | Real time PCR | JAK2 (Janus Kinase 2) V617F for MPDs | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
946 | BGPCR853 | Molecular | PCR + SEQUEN | Inter leukin 28B (IL28B) Polymorphism | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
947 | BGPCR852 | Molecular | PCR + SEQUEN | IRMA (Imatinib Resistance Mutation Assay) | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
948 | BGPCR851 | Molecular | Real time PCR | HPV - Human Papiloma Virus 16, 18 & High Risk Genotyping | EMB / body fluids / cervical swab | Daily | 2 DAYS |
949 | BGPCR850 | Molecular | PCR + SEQUEN | HIV -1 DRUG RESISTANCE ASSAY (PI, NRTI, NNRTI,INSTI) | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 21 DAYS |
950 | BGPCR849 | Molecular | Real time PCR | HIV1 MONITORING ( Viral Load & CD4/CD8) | 2 - 3 ml – Serum / Plasma & PB in EDTA | Daily | 2 DAYS |
951 | BGPCR848 | Molecular | Real time PCR | HIV 1 RNA QUANTITATIVE (Viral Load) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
952 | BGPCR847 | Molecular | Real time PCR | HIV 1 RNA Qualitative (Detection) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
953 | BGPCR846 | Molecular | Real time PCR | HIV1 Proviral DNA Qualitative PCR | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
954 | BGPCR845 | Molecular | Real time PCR | HSV (Herpes Simplex Virus) 1 & 2 Qual PCR | 2 - 3 ml – PB in EDTA / CSF / Fluids | Daily | 2 DAYS |
955 | BGPCR844 | Molecular | PCR | HLA typing – A, B, C, DQ, DR ( BMT) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
956 | BGPCR843 | Molecular | PCR | HLA typing – A, B, C, DQ, DR ( NEPHRO) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
957 | BGPCR842 | Molecular | PCR | HLA typing – DR & DQB1 (Class II) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
958 | BGPCR841 | Molecular | PCR | HLA typing – DRB (Class I & II) - TEST NOT AVAILABLE | XXXX | Daily | 5 DAYS |
959 | BGPCR840 | Molecular | PCR | HLA typing – ABC (Class I) - TEST NOT AVAILABLE | XXXX | Daily | 5 DAYS |
960 | BGPCR839 | Molecular | PCR | HLA typing – AB (Class I) - TEST NOT AVAILABLE | XXXX | Daily | 5 DAYS |
961 | BGPCR838 | Molecular | Real time PCR | HLA B5701 PCR ASSAY (Abacavir Hypersensitivity) | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
962 | BGPCR837 | Molecular | Real time PCR | HLA B27 Qualitative PCR ASSAY | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
963 | BGPCR836 | Molecular | PCR + SEQUEN | Hepatitis C Virus (HCV) – Genotyping | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
964 | BGPCR835 | Molecular | Real time PCR | Hepatitis C Virus (HCV) RNA – Quantitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
965 | BGPCR834 | Molecular | Real time PCR | Hepatitis C Virus (HCV) RNA– Qualitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
966 | BGPCR833 | Molecular | PCR + SEQUEN | Hepatitis B Virus (HBV) Drug Resistance Studies | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 4 DAYS |
967 | BGPCR832 | Molecular | PCR + SEQUEN | Hepatitis B Virus (HBV) – Genotyping | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
968 | BGPCR831 | Molecular | Real time PCR | Hepatitis B Virus (HBV) DNA – Quantitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
969 | BGPCR830 | Molecular | Real time PCR | Hepatitis B Virus (HBV) DNA– Qualitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 2 DAYS |
970 | BGPCR829 | Molecular | Real time PCR | Helicobacter Pylori – Qualitative PCR | 2 - 3 ml – SERUM / Blood / FECUS | Daily | 2 DAYS |
971 | BGPCR828 | Molecular | REAL TIME PCR | GENEXPERT MTB with rifampicin resistance, qualitative | 2 - 3 ml Sputum / BAL / CSF /Body fluids | Daily | 2 DAYS |
972 | BGPCR827 | Molecular | Sequencing | FRAGILE X SYNDROME ( FMR1 GENE) SANGER'S SEQUENCING | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
973 | BGPCR826 | Molecular | PCR + RFLP | FLT3 (fms like tyrosine kinase 3) Gene Mutation Assay | 2 - 3 ml – WB / BM in Sodium EDTA | Daily | 4 DAYS |
974 | BGPCR825 | Molecular | real time PCR | BLANK - NO TEST IS ASSIGNED | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
975 | BGPCR824 | Molecular | real time PCR | FACTOR V LEIDEN Mutation Assay | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
976 | BGPCR823 | Molecular | Real Time PCR | FACTOR II (PROTHROMBIN) Mutation Assay | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
977 | BGPCR822 | Molecular | Real time PCR | Epstein Barr Virus (EBV) Qualitative PCR Assay | Plasma, Serum, body fluids | Daily | 3 DAYS |
978 | BGPCR821 | Molecular | PCR + SEQUEN | EGFR Mutation Study (10 Mutations) | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
979 | BGPCR820 | Molecular | PCR + SEQUEN | DPYD Gene Mutations (5-FLOURO URACIL toxicity) detection | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
980 | BGPCR819 | Molecular | PCR | DUCHNE MUSCULAR DYSTROPHY (DMD) (26 exons) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
981 | BGPCR818 | Molecular | Real Time PCR | CYSTIC FIBROSIS (4 MUTATIONS) | 2 - 3 ml – PB in EDTA | Daily | 2 DAYS |
982 | BGPCR817 | Molecular | Real time PCR | CYTOMEGALO VIRUS (CMV) – Quantitative PCR | 2 - 3 ml – PB in EDTA / body fluids | Daily | 3DAYS |
983 | BGPCR816 | Molecular | Real time PCR | CYTOMEGALO VIRUS (CMV) – Qualitative PCR | 2 - 3 ml – PB in EDTA / body fluids | Daily | 3DAYS |
984 | BGPCR815 | Molecular | Real Time PCR | Chlamydia trachomatis – Qualitative PCR | Genital/Urethral swab/ body fluids | Daily | 3DAYS |
985 | BGPCR814 | Molecular | Real Time PCR | CEBPA (CCAAT/Enhancer Binding Protein ?) mutations | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
986 | BGPCR813 | Molecular | PCR + Sequencing | Calreticulin (CAL R) gene mutations | 2 - 3 ml – WB in K2 EDTA | Daily | 3DAYS |
987 | BGPCR812 | Molecular | PCR + Sequencing | BRACA 1 & BRACA 2 | 4 - 6 ml – WB in K2 EDTA | Daily | 28 days |
988 | BGPCR811 | Molecular | Real time PCR | BRAF Mutation (Proto-Oncogene) | Paraffin Embedded Tissue Block | Daily | 3DAYS |
989 | BGPCR810 | Molecular | Real time PCR | JC / BK Virus DNA PCR QUALITATIVE | 2 - 3 ml – Serum/ PB in K2 EDTA | Daily | 3DAYS |
990 | BGPCR809 | Molecular | Real time PCR | BCR/ABL (ALL) Minor (p190) Qualitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
991 | BGPCR808 | Molecular | Real time PCR | BCR/ABL (CML) Major (p210) Quantitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
992 | BGPCR807 | Molecular | Real time PCR | BCR/ABL (CML) Major (p210) Qualitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
993 | BGPCR806 | Molecular | Real Time PCR | Beta THALASSEMIA MUTATIONS | 2 - 3 ml – WB in K2 EDTA | Daily | 5 DAYS |
994 | BGPCR805 | Molecular | Real time PCR | Adenovirus DNA PCR Qualitative PCR assay | 2 - 3 ml – WB in K2 EDTA | Daily | 2DAYS |
995 | BGPCR804 | Molecular | real time PCR | MTB MDR2 - Mycobacterial Drug Resistance Assay -2 FLUOROQUINOLONES, CAPREOMYCIN, VIOMYCIN, AMIKACIN, KANAMYCIN, ETHAM | Sputum, BAL, Tissue, Bronchial wash | Daily | 2 DAYS |
996 | BGPCR803 | Molecular | real time PCR | MTB MDR1 - Mycobacterial Drug Resistance Assay -1 RIFAMPICIN, ISONNIAZID | Sputum, BAL, Tissue, Bronchial wash | Daily | 2 DAYS |
997 | BGPCR802 | Molecular | Real Time PCR | AML PCR PANEL - AML1(21q22) and ETO(8q22), INV 16 (p13;q22), PML (15q22) and RARa(17q21) - t(15;17) (q21;q22), MLL | 2 - 3 ml – WB / BM in K2 EDTA | Daily | 6 DAYS |
998 | BGPCR801 | Molecular | Real Time PCR | ALL PCR PANEL - BCR / ABL - t (9;22)(q34;q11) E2A/ PBX1 - t(1;19) MLL1 / AF4 - t(4;11), TEL / AML1 - t(12;21) | 2 - 3 ml – WB / BM in K2 EDTA | Daily | 6 DAYS |